Other nutritional deficiencies

E4_NUTRIDEF

nutritional disorder: Any condition related to a disturbance between proper intake and utilization of nourishment.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E50-E64, E65-E68 Cause of death: ICD-10 — E50-E64, E65-E68 2 out of 7 registries used, show all original rules.	33820
4. Check minimum number of events None	33820
5. Include endpoints E4_VIT_DEF E4_CA_DEF E4_SELE_DEF E4_ZINC_DEF E4_COPP_DEF E4_FE_DEF E4_MG_DEF E4_MANG_DEF E4_CHRO_DEF E4_MOLYB_DEF E4_VANA_DEF E4_MULTI_DEF E4_NUTRIEL_NAS_DEF E4_FAT_DEF E4_IMBAL_FOOD E4_NUTRI_DEF_NAS E4_SEQUMAL	34449
6. Filter based on genotype QC (FinnGen only)	34449

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	E4_NUTRIDEF
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_VIT_DEF\|E4_CA_DEF\|E4_SELE_DEF\|E4_ZINC_DEF\|E4_COPP_DEF\|E4_FE_DEF\|E4_MG_DEF\|E4_MANG_DEF\|E4_CHRO_DEF\|E4_MOLYB_DEF\|E4_VANA_DEF\|E4_MULTI_DEF\|E4_NUTRIEL_NAS_DEF\|E4_FAT_DEF\|E4_IMBAL_FOOD\|E4_NUTRI_DEF_NAS\|E4_SEQUMAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E[5-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E[5-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other nutritional deficiencies based on the number of shared cases.

Similar with more cases:

Endocrine, nutritional and metabolic diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	34449	22915	11534
Unadjusted period prevalence (%)	6.90	7.81	5.08
Median age at first event (years)	50.90	47.99	56.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
30337: Matched controls
299150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

QBJ30

NOMESCO Finland

Correction of abdominal apron

36.0

323.0

852

240

R5140

NOMESCO Finland

Monitoring the use of the aid

5.0

323.0

5370

12344

WX722

NOMESCO Finland

PEEP

5.3

323.0

2167

4242

103

Kela drug reimbursment

Diabetes, insulin-treated

4.3

323.0

11317

36689

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.3

323.0

2820

8924

B01AB05

ATC

enoxaparin; parenteral

2.3

323.0

9706

51151

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.7

323.0

1170

2102

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

10.9

323.0

3377

3385

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

11.1

323.0

3748

3754

A10BX04

ATC

[U] exenatide; parenteral

19.0

323.0

826

439

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

323.0

5813

31519

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

20.7

323.0

939

461

WX110

NOMESCO Finland

Local anesthesy

1.7

323.0

21070

169010

N02BE01

ATC

paracetamol; systemic, rectal

2.7

323.0

26587

216076

SPAT1263

SPAT

Sampling

1.7

323.0

12863

89082

160

Kela drug reimbursment

exenatide

18.1

323.0

1737

998

162

Kela drug reimbursment

liraglutide

18.1

323.0

915

514

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

323.0

3365

15082

L28

ICPC

Limited function/disability (L)

2.2

323.0

4117

19673

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1879.8

323.0

707

SPAT1310

SPAT

Counselling related to known health issue

1.7

323.0

9418

62356

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.2

323.0

10742

34273

S18

ICPC

Laceration/cut

1.7

323.0

11327

79145

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

323.0

9369

47675

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.2

323.0

2126

3585

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.6

323.0

4884

15256

H03AA01

ATC

levothyroxine sodium; systemic

1.9

323.0

7068

41498

XG466

NOMESCO Finland

Sleep oxymetry

6.1

323.0

1633

2767

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

323.0

4850

24056

RD210

NOMESCO Finland

8.0

323.0

1132

1443

A10BJ06

ATC

semaglutide; parenteral

9.9

323.0

2220

2359

205

Kela drug reimbursment

Chronic hypertension

2.7

323.0

8156

35996

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

323.0

11931

84140

J01DB01

ATC

cefalexin; oral

2.2

323.0

25322

208308

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.5

323.0

1194

2213

C09AA05

ATC

ramipril; oral

1.9

323.0

5858

33419

A10BK01

ATC

dapagliflozin; oral

4.5

323.0

1861

4264

R4190

NOMESCO Finland

Nutritional therapy

5.8

323.0

1829

3298

A10BK03

ATC

empagliflozin; oral

4.8

323.0

3260

7350

WX290

NOMESCO Finland

Other blockade of nerve

1.6

323.0

13876

102446

M04AA01

ATC

allopurinol; systemic

3.3

323.0

4023

13178

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

323.0

8614

52820

WX780

NOMESCO Finland

Remote monitoring CPAP

3.8

323.0

1536

4118

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.9

323.0

4175

15836

T82

ICPC

Obesity

13.5

323.0

3472

2843

H02AB06

ATC

prednisolone; systemic

1.9

323.0

14087

94520

OAB72

NOMESCO Finland

Weight control and weight loss guidance

25.3

323.0

554

220

N03AX16

ATC

pregabalin; oral

2.1

323.0

7273

39846

L17

ICPC

Foot/toe symptom/complaint

1.8

323.0

7168

43261

I10

ICD-10 Finland

Essential (primary) hypertension

3.0

323.0

18052

98412

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.9

323.0

3956

8838

M10.9

ICD-10 Finland

Gout, unspecified

3.4

323.0

1898

5761

N06AB04

ATC

citalopram; systemic

2.0

323.0

6887

37870

C09CA01

ATC

losartan; oral

1.9

323.0

6121

35540

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

323.0

3855

17132

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

35.5

323.0

521

147

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

323.0

3592

15757

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.7

323.0

8731

39537

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

323.0

12636

77796

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

323.0

3698

13591

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3169.0

323.0

2454

N02AX02

ATC

tramadol; systemic, rectal

2.2

323.0

13591

79593

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

323.0

5830

32507

E66.9

ICD-10 Finland

Obesity, unspecified

142.4

323.0

5896

506

R06.5

ICD-10 Finland

Mouth breathing

2.5

323.0

2837

11887

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

323.0

3069

13304

T90

ICPC

Diabetes non-insulin dependent

4.1

323.0

9588

30520

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.1

323.0

3461

12102

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

323.0

14126

97133

N06AX21

ATC

duloxetine; oral

2.4

323.0

3768

16532

E66.00

ICD-10 Finland

Metabolic syndrome

56.0

323.0

8022

1908

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

323.0

3361

15355

R03AC02

ATC

salbutamol; inhalant

2.1

323.0

17368

116098

A10BH05

ATC

linagliptin; oral

4.0

323.0

1466

3732

M79.6

ICD-10 Finland

Pain in limb

1.8

323.0

10787

68747

G47.3

ICD-10 Finland

Sleep apnoea

5.9

323.0

12121

30405

B03BA03

ATC

hydroxocobalamin; parenteral

4.1

323.0

1985

5072

C10AA01

ATC

simvastatin; oral

1.9

323.0

10445

65671

A10BA02

ATC

metformin; oral

5.3

323.0

13060

37398

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

323.0

6279

27753

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

323.0

8058

50391

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.5

323.0

5933

19335

E66.8

ICD-10 Finland

Other obesity

226.6

323.0

10084

656

A10AE05

ATC

insulin detemir; parenteral

3.4

323.0

2056

6294

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.5

323.0

4470

19038

C10AA05

ATC

atorvastatin; oral

1.7

323.0

9099

60110

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.0

323.0

6375

18696

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

323.0

3777

16061

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

323.0

11359

75633

E66.01

ICD-10 Finland

Obesity due to excess calories

158.2

323.0

15779

2038

A10BH01

ATC

sitagliptin; oral

4.6

323.0

4075

9674

I50.9

ICD-10 Finland

Heart failure, unspecified

3.4

323.0

3533

11259

A10BB12

ATC

glimepiride; oral

4.4

323.0

2416

5808

A10BX07

ATC

[U] liraglutide; parenteral

19.1

323.0

1065

570

I50.0

ICD-10 Finland

Congestive heart failure

3.6

323.0

1740

4973

R60.0

ICD-10 Finland

Localized oedema

2.6

323.0

3340

13430

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

323.0

4215

20580

C08CA01

ATC

amlodipine; oral

2.1

323.0

9645

53645

N06AX16

ATC

venlafaxine; oral

2.3

323.0

5052

23784

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

323.0

4160

20270

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.3

323.0

10641

27844

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.2

323.0

1093

2125

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.3

323.0

2798

9009

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

323.0

4625

20676

R06.0

ICD-10 Finland

Dyspnoea

2.4

323.0

8096

38881

A08AB01

ATC

orlistat; oral

21.0

323.0

565

270

J01FF01

ATC

clindamycin; systemic

2.0

323.0

8589

49923

J01AA02

ATC

doxycycline; systemic

1.7

323.0

22621

187937

C03DA01

ATC

spironolactone; oral

3.1

323.0

3391

11636

N05AH04

ATC

quetiapine; oral

2.2

323.0

5632

28066

J01DA01

ATC

[U] cefalexin; systemic

1.7

323.0

18534

145631

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.8

323.0

3401

4781

A46

ICD-10 Finland

Erysipelas

3.0

323.0

4763

17222

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

10357

65087

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

511.4

323.0

1392

K02.1

ICD-10 Finland

Caries of dentine

1.6

323.0

17287

135192

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.2

323.0

5313

26490

A10AE04

ATC

insulin glargine; parenteral

3.8

323.0

3893

11039

C03CA01

ATC

furosemide; systemic

3.6

323.0

9397

33183

C07AB07

ATC

bisoprolol; oral

2.1

323.0

13114

79462

A10BG03

ATC

pioglitazone; oral

5.6

323.0

1017

1841

SPAT1262

SPAT

Handing over of treatment supplies

3.3

323.0

7209

25502

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

323.0

4095

16816

R02

ICPC

Shortness of breath/dyspnoea

2.3

323.0

3595

16793

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

323.0

5581

28151

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

323.0

10751

73322

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

323.0

5833

29133

L15

ICPC

Knee symptom/complaint

1.9

323.0

5888

33873

A10BJ02

ATC

liraglutide; parenteral

14.0

323.0

1821

1361

A10BJ01

ATC

exenatide; parenteral

13.7

323.0

597

437

E66.0

ICD-10 Finland

Obesity due to excess calories

403.4

323.0

1489

C03AA03

ATC

hydrochlorothiazide; oral

2.7

323.0

2729

10466

E66

ICD-10 Finland

Obesity

15.0

323.0

4311

3257

N06AB03

ATC

fluoxetine; oral

2.2

323.0

4193

20039

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

19458

142005

C09AA02

ATC

enalapril; systemic

2.2

323.0

5211

25765

S97

ICPC

Chronic ulcer skin

3.4

321.4

1672

4997

A10BD07

ATC

metformin and sitagliptin; systemic

3.7

319.9

1498

4112

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

319.8

12063

86585

C08CA13

ATC

lercanidipine; oral

2.3

318.5

3408

15788

B01AA03

ATC

warfarin; systemic

2.0

314.6

4383

22797

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

311.2

9039

60284

N03AX12

ATC

gabapentin; oral

2.0

309.5

4528

24003

E66.1

ICD-10 Finland

Drug-induced obesity

163.4

309.1

328

N06AX12

ATC

bupropion; oral

2.7

307.9

2342

9042

SPAT1254

SPAT

Administration of medicine

2.1

306.5

4103

20972

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

304.5

2453

9791

L03

ICPC

Low back symptom/complaint

1.8

303.1

7065

44061

B81

ICPC

Anaemia vit B12/folate deficiency

4.1

302.1

1248

3064

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

301.8

4664

25232

R03BB04

ATC

tiotropium bromide; inhalant

2.5

301.7

2618

10887

N05BA04

ATC

oxazepam; oral

1.7

296.0

7106

44664

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

295.2

16271

127400

J96.1

ICD-10 Finland

Chronic respiratory failure

7.1

294.1

758

1079

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

293.1

5431

31359

R03BA05

ATC

fluticasone; inhalant

1.9

293.0

5492

31834

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.9

292.5

1279

3305

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

290.6

2194

8425

T83

ICPC

Overweight

5.5

287.8

900

1649

C02AC05

ATC

moxonidine; oral

3.6

286.5

1397

3959

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

285.7

2965

13491

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.8

285.7

1321

3582

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

285.3

2840

12662

N06AB10

ATC

escitalopram; oral

1.8

283.9

6332

38818

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

283.1

2618

11242

J01MA12

ATC

levofloxacin; systemic

1.9

281.5

4938

27916

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

279.8

13370

100640

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.9

276.3

964

1998

WX723

NOMESCO Finland

CPAP therapy

3.6

273.0

1321

3717

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.4

273.0

2537

10913

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.3

272.5

2842

12946

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

271.1

7701

50616

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

269.7

6081

37318

EBA00

NOMESCO Finland

Extraction of tooth

1.6

268.7

9467

65902

M25.5

ICD-10 Finland

Pain in joint

1.6

266.8

8235

55333

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

266.1

3207

15601

SPAT1301

SPAT

No procedures

1.6

265.8

8660

59028

C09DA01

ATC

losartan and diuretics; oral

2.3

263.4

2781

12730

E61.1

ICD-10 Finland

Iron deficiency

5.5

263.3

829

1530

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

262.9

2185

8844

J01FA06

ATC

roxithromycin; oral

1.6

262.7

11366

83124

C09BA02

ATC

enalapril and diuretics; systemic

2.5

262.0

2187

8875

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

261.1

4796

27477

P01AB01

ATC

metronidazole; oral, rectal

1.6

260.7

11420

83721

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

260.7

2758

12635

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

260.3

5663

34309

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

260.0

8672

59393

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.5

259.6

808

1471

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

259.2

14921

116441

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

257.6

4799

27614

J45

ICD-10 Finland

Asthma

2.2

255.9

2972

14204

M01AH05

ATC

etoricoxib; oral

1.5

255.1

16657

133478

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

255.1

6787

43654

R03BA02

ATC

budesonide; inhalant

1.8

253.8

5104

30117

M01AE02

ATC

naproxen; oral, rectal

1.5

253.0

16513

132199

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

19.8

251.9

390

197

M01AB05

ATC

diclofenac; systemic, rectal

1.5

249.9

18958

156692

C07AB02

ATC

metoprolol; systemic

1.8

248.5

4768

27674

N06AX11

ATC

mirtazapine; oral

1.6

247.3

8776

60898

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

245.5

3086

15251

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

245.3

2023

8144

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.9

244.9

1075

2782

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

244.8

14163

110069

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

244.2

4699

27283

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

242.3

2641

12248

SPAT1240

SPAT

Therapeutic discussion

2.0

242.3

3577

18868

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

241.6

5524

33884

N05CF01

ATC

zopiclone; oral

1.6

238.9

8189

56212

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

238.9

3362

17396

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

238.8

1733

6473

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

238.7

3691

19810

N06AB06

ATC

sertraline; oral

2.0

238.0

3439

17980

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

236.6

2748

13108

A28

ICPC

Limited function/disability NOS

2.0

235.3

3169

16104

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

232.7

4811

28552

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

232.5

4866

28990

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

232.4

6987

46282

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

232.0

3707

20124

R03DC03

ATC

montelukast; oral

1.8

230.3

4736

28046

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

229.7

15404

122862

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

229.1

20384

172567

P76

ICPC

Depressive disorder

2.4

228.4

2151

9279

A02BC01

ATC

omeprazole; systemic

1.6

228.3

7221

48440

358

Kela drug reimbursment

liraglutide

17.0

227.9

372

218

C09CA06

ATC

candesartan; oral

1.7

227.6

5673

35621

R06AE07

ATC

cetirizine; oral

1.5

227.3

12648

96876

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

227.2

16741

136037

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

226.6

1416

4803

M03BX02

ATC

tizanidine; oral

1.5

225.9

17897

147561

N05AX12

ATC

aripiprazole; systemic

3.0

224.5

1411

4805

A10BJ05

ATC

dulaglutide; parenteral

10.1

223.9

463

459

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

15.7

220.7

372

237

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

220.2

4134

23722

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

219.8

6566

43310

R05FB02

ATC

cough suppressants and expectorants

1.5

219.4

9852

71812

SPAT1229

SPAT

Assessment of need for aid

2.4

219.3

2026

8649

P06

ICPC

Sleep disturbance

2.0

218.6

2946

14948

R53

ICD-10 Finland

Malaise and fatigue

1.7

218.4

5477

34399

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

218.4

3526

19183

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

216.2

2319

10647

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

214.8

7314

49853

N02AA05

ATC

oxycodone; systemic

1.9

214.8

3366

18103

SPAT1312

SPAT

General health counselling

1.5

213.2

9075

65238

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

213.1

3273

17465

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

213.0

5433

34256

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

211.9

3636

20203

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.7

211.7

1524

5653

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

211.1

7217

49201

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

211.0

11165

84159

207

Kela drug reimbursment

Chronic arrhythmias

2.0

210.7

2962

15273

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

210.3

20659

176635

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

210.2

9861

72396

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

210.0

4621

27870

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

209.7

6690

44798

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

209.0

10921

82048

ACC51

NOMESCO Finland

Release of median nerve

2.3

207.2

2173

9865

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

206.0

2047

9052

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

205.8

1997

8727

J46

ICD-10 Finland

Status asthmaticus

3.7

205.4

947

2553

R03AC03

ATC

terbutaline; inhalant

1.8

204.9

4006

23248

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.9

203.9

1311

4526

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

203.5

7176

49215

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

201.0

1325

4649

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

200.7

997

2857

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

199.7

2911

15205

UJF32

NOMESCO Finland

Coloscopy

1.6

199.1

6349

42419

A08AA10

ATC

sibutramine; oral

22.7

198.8

294

129

C01DA14

ATC

isosorbide mononitrate; oral

2.0

198.0

2808

14507

SPAT1260

SPAT

Consultation of another employee

1.7

197.9

4812

29843

K04.0

ICD-10 Finland

Pulpitis

1.9

197.8

3066

16391

J20

ICD-10 Finland

Acute bronchitis

2.0

197.5

2701

13754

A06AD11

ATC

lactulose; oral

1.9

197.5

3205

17420

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.8

197.2

521

767

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.4

197.1

628

1174

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

196.5

1363

4939

M48.0

ICD-10 Finland

Spinal stenosis

2.0

196.3

2763

14229

P03

ICPC

Feeling depressed

2.0

196.1

2917

15348

SPAT1139

SPAT

Nutrition survey

3.3

195.9

1075

3324

N03AX09

ATC

lamotrigine; oral

2.5

195.0

1639

6640

A08

ICPC

Swelling

3.0

195.0

1187

3950

N06AA09

ATC

amitriptyline; systemic

2.0

194.9

2660

13527

S76

ICPC

Skin infection other

2.7

194.2

1472

5625

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

194.0

1464

5581

J01MA02

ATC

ciprofloxacin; systemic

1.5

193.5

9803

72832

J01CA04

ATC

amoxicillin; systemic

1.5

192.3

23693

209935

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

11.3

191.9

374

331

R4110

NOMESCO Finland

Physiotherapy

1.6

191.3

6872

47217

R01AD09

ATC

mometasone; nasal

1.4

190.6

12899

101510

M10

ICD-10 Finland

Gout

3.1

188.0

1134

3749

I50

ICD-10 Finland

Heart failure

4.2

185.4

740

1752

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

184.8

2851

15190

C09DA06

ATC

candesartan and diuretics; oral

2.3

184.2

1893

8494

N05AA02

ATC

levomepromazine; systemic

2.8

184.1

1280

4642

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.9

183.4

634

1298

L16

ICPC

Ankle symptom/complaint

1.9

183.2

2797

14840

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

182.7

2032

9459

A10BB01

ATC

glibenclamide; oral

3.6

182.4

886

2492

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

182.4

3395

19323

R51.80

ICD-10 Finland

Headache

1.7

182.0

4274

26171

C09CA03

ATC

valsartan; oral

2.1

181.5

2154

10321

K07

ICPC

Swollen ankles/oedema

3.1

181.3

1095

3622

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

180.9

3027

16600

A02BC05

ATC

esomeprazole; systemic

1.4

180.4

10610

80945

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

7.6

179.5

440

581

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.5

179.3

671

1492

SPAT1211

SPAT

Application of soft bandage

2.0

179.1

2449

12447

M02AA07

ATC

piroxicam; topical

1.5

179.0

9063

67043

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

178.4

3087

17127

H02AB04

ATC

methylprednisolone; systemic

1.7

177.7

3849

22986

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.2

177.6

988

3083

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

177.4

2165

10494

R96

ICPC

Asthma

2.0

177.4

2356

11830

SPAT1255

SPAT

Intravenous administration of medicine

2.3

176.3

1782

7926

H02AB07

ATC

prednisone; oral

1.8

176.2

3682

21740

26998

ICD-8 Finland

Other nutritional deficiency, Aliae definitae

+∞

175.2

169

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

175.0

4225

26050

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

175.0

2219

10929

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

172.3

1314

5034

J01FA09

ATC

clarithromycin; systemic

1.5

171.8

8790

65032

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

171.5

2505

13053

N05BA01

ATC

diazepam; systemic, rectal

1.8

171.1

3443

20072

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

170.5

3517

20661

C08CA02

ATC

felodipine; oral

2.1

169.7

2030

9747

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

168.9

5907

40131

W85

ICPC

Gestational diabetes

2.6

168.6

1287

4931

M79.7

ICD-10 Finland

Fibromyalgia

2.9

168.5

1130

4002

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

168.0

4027

24753

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

167.9

2974

16613

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

167.9

1929

9099

A02BC03

ATC

lansoprazole; oral

1.5

167.6

7261

51801

S10

ICPC

Boil/carbuncle

2.4

167.3

1555

6633

N05AX08

ATC

risperidone; systemic

2.1

167.2

1954

9285

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.8

166.7

1161

4211

W84

ICPC

Pregnancy high risk

2.8

166.4

1178

4314

SPAT1283

SPAT

Restricted health certificate

1.6

166.0

5644

38057

C10AA07

ATC

rosuvastatin; oral

1.6

165.9

5471

36616

SPAT1216

SPAT

Assessment of functional ability

1.8

165.3

3396

19913

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

165.3

1973

9462

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

163.6

2429

12724

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

163.5

3795

23092

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.1

162.7

956

3100

N05CD07

ATC

temazepam; oral

1.9

162.4

2739

15028

E65

ICD-10 Finland

Localized adiposity

68.9

161.9

188

D07AC01

ATC

betamethasone; topical

1.5

161.0

8766

65471

T07

ICPC

Weight gain

5.5

158.0

492

895

WZA90

NOMESCO Finland

Other doctors statement

1.5

157.5

6297

44023

A10BX01

ATC

guar gum; systemic

3.0

157.3

952

3151

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.0

157.1

530

1057

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

156.9

1903

9180

R03BA01

ATC

beclometasone; inhalant

1.7

156.9

3681

22445

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

156.6

2503

13464

M10.0

ICD-10 Finland

Idiopathic gout

3.4

156.0

817

2436

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

155.7

2265

11764

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

155.6

1928

9387

A10BG02

ATC

rosiglitazone; oral

5.6

154.3

472

841

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

154.2

1670

7662

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.2

153.5

1652

7555

M54

ICD-10 Finland

Dorsalgia

1.8

153.5

3109

18118

N62

ICD-10 Finland

Hypertrophy of breast

2.5

152.6

1286

5202

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.0

152.5

644

1606

R05

ICPC

Cough

1.5

152.4

5880

40728

Z71.8

ICD-10 Finland

Other specified counselling

1.5

152.3

6527

46281

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

151.3

2593

14289

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

151.3

1929

9501

WX002

NOMESCO Finland

Sedation and analgesia

1.6

151.0

4774

31525

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

150.8

10604

82848

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

150.7

3379

20309

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

150.6

3417

20610

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.0

150.6

646

1634

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

6.6

150.5

405

612

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.1

150.3

623

1527

E0000UV

ATC

1.4

150.3

10549

82374

A10BD03

ATC

metformin and rosiglitazone; systemic

5.2

149.1

489

945

A12BA01

ATC

potassium chloride; oral

3.0

148.7

927

3129

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

148.4

1541

6927

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

147.5

7634

56227

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.3

147.3

788

2387

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.7

147.2

691

1888

107

Kela drug reimbursment

Pernicious anaemia

4.3

146.9

575

1336

B01AF02

ATC

apixaban; oral

2.0

146.9

1952

9774

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

145.0

2313

12420

SPAT1153

SPAT

Removal of sutures

1.4

144.9

7763

57527

F34.1

ICD-10 Finland

Dysthymia

2.6

144.7

1131

4388

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.3

144.5

403

639

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

143.0

949

3336

C09DA03

ATC

valsartan and diuretics; oral

2.5

142.7

1191

4791

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.3

142.7

1370

5930

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

142.1

1049

3936

AA1AD

NOMESCO Finland

CT of head and brain

1.5

142.0

5256

35982

A10BH02

ATC

vildagliptin; oral

4.1

141.9

582

1413

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

141.2

1366

5934

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

139.9

3229

19546

D11

ICPC

Diarrhoea

1.7

139.5

3134

18815

A01

ICPC

Pain general/multiple sites

2.0

139.3

1961

10038

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

139.2

5737

40210

R42

ICD-10 Finland

Dizziness and giddiness

1.5

138.9

5001

33990

R03DA04

ATC

theophylline; systemic, rectal

2.5

138.6

1163

4691

C07AG02

ATC

carvedilol; oral

2.3

137.9

1332

5780

R06.2

ICD-10 Finland

Wheezing

2.4

136.8

1234

5173

L90

ICPC

Osteoarthrosis of knee

2.2

135.7

1420

6401

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

135.6

705

2090

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

135.5

1981

10287

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

135.5

900

3164

WX320

NOMESCO Finland

Spinalanesthesy

1.5

135.0

5535

38713

AN1

Coronary angiography

1.9

134.7

2320

12785

WZC30

NOMESCO Finland

Teaching

1.7

134.1

3275

20129

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

134.0

3123

18940

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

133.7

4375

29037

N06AX03

ATC

mianserin; oral

2.3

133.5

1279

5526

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

133.2

5722

40411

SPAT1097

SPAT

Recording of ECG

1.7

131.7

3339

20735

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

131.6

5439

38077

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

131.5

7234

53676

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

131.5

898

3211

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

130.8

7237

53751

E51.2

ICD-10 Finland

Wernicke encephalopathy

266.4

130.5

134

D01AC02

ATC

miconazole; topical

2.0

130.4

1904

9874

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

129.7

947

3530

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

129.3

3642

23259

S80.0

ICD-10 Finland

Contusion of knee

2.0

129.2

1790

9098

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.8

129.2

2662

15544

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

128.8

2435

13834

K04.08

ICD-10 Finland

Other specified pulpit

1.9

127.9

1908

9974

M01AX17

ATC

nimesulide; oral

1.5

127.7

5689

40433

M01AX05

ATC

glucosamine; oral

1.6

127.5

4136

27362

J01FA10

ATC

azithromycin; systemic

1.3

127.1

16486

140874

K08.3

ICD-10 Finland

Retained dental root

2.0

126.0

1695

8514

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.1

125.8

511

1230

E000001

ATC

1.5

124.9

5414

38230

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.4

123.9

1082

4457

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

123.9

18349

159670

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

123.5

1223

5367

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

123.3

6094

44194

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

123.2

1689

8544

H3600, E113

ICD-10 Finland

5.2

123.2

402

773

AA40B

NOMESCO Finland

9.2

123.0

266

287

N03AG01

ATC

valproic acid; systemic, rectal

2.0

122.6

1655

8321

A03

ICPC

Fever

1.5

122.3

4421

29980

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

121.7

2250

12682

B01AF01

ATC

rivaroxaban; oral

1.8

121.4

2461

14284

R50.9

ICD-10 Finland

Fever, unspecified

1.6

120.9

3436

21961

A04

ICPC

Weakness/tiredness general

1.6

120.8

3155

19719

XX_20

NOMESCO Finland

Bioimpedance measurement

44.0

120.8

151

N06AX26

ATC

vortioxetine; oral

2.0

120.5

1600

7989

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

120.4

2515

14734

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

120.1

2068

11374

C01AA05

ATC

digoxin; systemic

2.2

120.0

1319

6076

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

120.0

2297

13090

R74

ICPC

Upper respiratory infection acute

1.4

119.6

8084

62062

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

119.3

3618

23505

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

119.2

4365

29667

A10BX09

ATC

[U] dapagliflozin; oral

5.6

118.8

361

639

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

118.7

2951

18184

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

117.9

1098

4673

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.7

117.8

2613

15582

R11

ICD-10 Finland

Nausea and vomiting

1.9

117.5

1999

10945

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

117.5

774

2704

D07AC13

ATC

mometasone; topical

1.4

117.0

7324

55424

L60.0

ICD-10 Finland

Ingrowing nail

2.3

116.8

1147

5012

SPAT1104

SPAT

Monitoring of emergency patient

2.0

116.4

1622

8254

M01AC06

ATC

meloxicam; systemic, rectal

1.4

116.3

9095

71478

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

116.2

1576

7934

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

7.9

116.2

275

345

R01AD08

ATC

fluticasone; nasal

1.4

115.9

7618

58130

SPAT1234

SPAT

Support of social functional capacity

2.3

115.9

1135

4952

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

115.6

3836

25458

S29

ICPC

Skin symptom/complaint other

1.5

114.8

3980

26689

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

114.7

4621

32051

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

114.3

1611

8234

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.1

113.8

651

2070

SPAT1281

SPAT

Other administrative function

1.8

113.5

2073

11624

J01CF05

ATC

flucloxacillin; systemic

2.4

113.3

1018

4251

M79.1

ICD-10 Finland

Myalgia

1.6

113.2

3340

21527

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.9

113.1

329

552

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

113.0

5053

35820

R03AC13

ATC

formoterol; inhalant

2.2

112.9

1235

5675

XF402

NOMESCO Finland

ECG with work load test

1.7

112.9

2423

14296

N05AH03

ATC

olanzapine; systemic

2.0

112.9

1604

8221

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

112.6

7527

57550

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

112.6

1944

10694

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.6

112.2

341

604

G44.2

ICD-10 Finland

Tension-type headache

1.6

112.0

3515

23003

H3601, E113

ICD-10 Finland

4.4

112.0

427

968

F32

ICD-10 Finland

Depressive episode

2.0

111.8

1525

7694

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

111.7

612

1887

ZXA00

NOMESCO Finland

Right side

1.4

111.0

6117

45148

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

110.4

8561

67047

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

110.2

1051

4526

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.5

110.1

408

899

I50.1

ICD-10 Finland

Left ventricular failure

2.5

109.9

886

3490

SPAT1058

SPAT

PEF monitoring instruction

1.8

109.6

2008

11266

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

109.0

2757

17045

R32

ICD-10 Finland

Unspecified urinary incontinence

2.9

108.4

688

2348

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

108.3

7081

53857

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

108.2

11422

93742

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

108.0

4322

29892

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

107.7

5876

43250

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

107.7

1036

4477

B01AB04

ATC

dalteparin; parenteral

2.2

107.5

1182

5442

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

107.4

646

2126

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

107.4

1356

6624

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

107.4

2772

17234

J45.8

ICD-10 Finland

Mixed asthma

2.6

107.2

829

3192

N19

ICD-10 Finland

Unspecified kidney failure

2.9

107.1

701

2441

RD112

NOMESCO Finland

14.0

106.8

187

132

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

106.8

639

2097

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

106.0

3629

24223

N05AF03

ATC

chlorprothixene; systemic

2.6

105.9

805

3070

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

14.4

105.6

183

126

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.2

105.1

1156

5322

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

104.8

1777

9704

N05AN01

ATC

lithium; oral

2.7

104.7

755

2789

M01AB01

ATC

indometacin; systemic, rectal

1.9

104.1

1599

8435

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

104.0

2385

14337

XA420

NOMESCO Finland

Extensive sleep examination

4.4

104.0

400

915

J01MA14

ATC

moxifloxacin; systemic

1.8

103.4

2107

12223

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.9

103.3

661

2267

L14

ICPC

Leg/thigh symptom/complaint

1.9

102.7

1714

9310

P29

ICPC

Psychological sympt/compl other

1.9

102.4

1610

8561

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

102.2

1726

9414

R03AC12

ATC

salmeterol; inhalant

2.3

101.8

1027

4542

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

101.7

2893

18440

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

4.7

100.9

358

755

H01

ICPC

Ear pain/earache

1.6

100.8

2776

17541

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

100.7

2327

14008

L08

ICPC

Shoulder symptom/complaint

1.5

100.7

4391

30881

A02BA02

ATC

ranitidine; systemic

1.5

100.0

4364

30687

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.4

100.0

878

3623

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

99.8

1766

9782

P99

ICPC

Psychological disorders other

2.5

99.7

822

3278

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

98.6

1794

10031

N05BA12

ATC

alprazolam; oral

1.6

98.3

2514

15570

D07XC01

ATC

betamethasone, combinations; topical

1.6

97.5

2783

17740

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.2

97.5

1091

5061

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.4

97.4

499

1463

3051

Kela drug reimbursment

16.1

97.3

161

N05AB03

ATC

perphenazine; systemic, rectal

2.3

97.2

946

4110

J02AC01

ATC

fluconazole; systemic

1.3

96.9

11038

91116

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

96.9

642

2253

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

96.3

1595

8636

M01AH02

ATC

rofecoxib; oral

1.6

96.0

2864

18460

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

95.6

981

4372

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

56.4

95.5

114

B02AA02

ATC

tranexamic acid; systemic

1.5

95.5

3876

26820

P01

ICPC

Feeling anxious/nervous/tense

1.6

95.1

2894

18741

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

94.9

1953

11353

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

94.8

1243

6162

K78

ICPC

Atrial fibrillation/flutter

2.0

94.8

1356

6960

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

94.4

2545

15977

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

94.4

2046

12081

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

94.3

2377

14656

ZXA05

NOMESCO Finland

Left side

1.4

94.2

5624

41926

L86

ICPC

Back syndrome with radiating pain

1.9

94.0

1385

7185

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.5

93.5

458

1297

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

93.3

1432

7543

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

93.1

776

3113

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.2

93.0

372

884

N06AB05

ATC

paroxetine; oral

1.8

92.9

1628

8985

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

92.9

3000

19706

C09CA07

ATC

telmisartan; oral

1.8

92.3

1567

8554

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

92.2

968

4360

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

92.2

603

2099

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

91.9

523

1658

J96.0

ICD-10 Finland

Acute respiratory failure

4.7

91.6

329

703

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.2

91.2

502

1553

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

91.0

2163

13115

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

90.8

1147

5603

C10AB05

ATC

fenofibrate; oral

3.3

90.7

488

1485

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.2

90.5

994

4572

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.4

90.3

471

1401

D07AD01

ATC

clobetasol; topical

1.5

90.3

3648

25194

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.3

89.9

864

3732

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

89.8

1165

5750

C03BA11

ATC

indapamide; oral

2.7

89.6

652

2422

F50.8

ICD-10 Finland

Other eating disorders

7.1

89.6

227

317

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

89.5

1567

8643

M02AA10

ATC

ketoprofen; topical

1.5

89.3

3626

25063

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

89.2

2935

19352

R52.9

ICD-10 Finland

Pain, unspecified

1.7

89.1

1987

11823

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.8

89.0

602

2139

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.0

88.9

378

950

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

88.9

1159

5734

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

88.8

2636

16949

N03AX11

ATC

topiramate; oral

2.4

88.8

774

3180

N06AX05

ATC

trazodone; oral

2.5

88.8

719

2839

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

88.7

516

1659

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.0

88.6

536

1771

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

88.5

595

2107

C10AX09

ATC

ezetimibe; oral

1.6

88.4

2218

13649

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

88.1

1497

8172

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.6

88.1

666

2531

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

88.1

1101

5351

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

88.1

1675

9491

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

88.0

928

4188

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

87.9

2447

15476

R01AD12

ATC

fluticasone furoate; nasal

1.3

87.5

8000

63744

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

87.2

7760

61585

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

87.0

861

3771

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

87.0

1162

5804

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

86.9

1142

5667

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

86.7

1219

6211

N06AA12

ATC

doxepin; systemic

2.0

86.4

1207

6134

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

86.3

1163

5830

L13

ICPC

Hip symptom/complaint

1.5

86.1

3271

22272

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

86.0

1570

8778

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

86.0

1759

10198

SPAT1054

SPAT

Examination of peripheral nervous system

3.2

85.6

468

1442

SPAT1051

SPAT

Guidance regarding sleep disorders

3.2

85.3

481

1515

K85

ICPC

Elevated blood pressure

1.5

85.2

2943

19612

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

85.1

923

4217

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

85.0

JDF21

NOMESCO Finland

Laparoscopic gastric banding

+∞

85.0

C07BB07

ATC

bisoprolol and thiazides; systemic

2.2

84.9

878

3924

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.0

84.9

521

1737

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.8

84.9

1712

9878

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

84.7

681

2681

RD140

NOMESCO Finland

128.6

84.5

N05CF02

ATC

zolpidem; oral

1.4

84.3

4324

31279

XQ800

NOMESCO Finland

Prick test

1.7

84.0

2023

12301

N30.0

ICD-10 Finland

Acute cystitis

1.5

83.7

3219

21964

SPAT1377

SPAT

Polysomnography

2.2

83.6

875

3936

B01AB10

ATC

tinzaparin; parenteral

1.8

83.6

1554

8740

SPAT1252

SPAT

Overall medication plan or its review

1.8

83.4

1439

7893

A10AE06

ATC

insulin degludec; parenteral

2.3

83.3

781

3332

R04

ICPC

Breathing problem other

2.3

83.3

843

3732

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

83.2

1297

6865

B01AC04

ATC

clopidogrel; oral

1.5

83.2

2757

18193

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

83.1

476

1515

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

83.1

1444

7939

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

83.0

1431

7848

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

82.8

587

2147

SPAT1325

SPAT

Vaccination

1.3

82.6

7758

61953

A10AB06

ATC

insulin glulisine; parenteral

4.1

82.1

339

830

SPAT1094

SPAT

Continuous Positive Airway Pressure

3.9

82.0

353

898

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.4

81.9

739

3091

ZXA10

NOMESCO Finland

Bilateral

1.4

81.9

4083

29358

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

81.6

3091

21016

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

81.4

26014

243483

A99

ICPC

Disease/condition unspecnature/site

1.7

81.3

1777

10500

C09AA03

ATC

lisinopril; oral

2.1

81.2

963

4579

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

81.1

945

4457

JAH01

NOMESCO Finland

Laparoscopy

1.9

81.0

1211

6312

R05

ICD-10 Finland

Cough

1.4

81.0

4458

32642

OAB72

SPAT

7.8

81.0

192

243

G04BD12

ATC

mirabegron; oral

1.7

80.9

1971

12014

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

80.8

865

3928

E000003

ATC

2.0

80.8

1162

5972

Z01.2

ICD-10 Finland

Dental examination

1.3

80.7

10923

91552

Z50.1

ICD-10 Finland

Other physical therapy

1.9

80.3

1265

6721

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.2

80.2

322

769

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

80.1

3053

20779

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.8

79.9

1476

8280

A10BX02

ATC

repaglinide; oral

4.1

79.8

326

791

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

79.4

904

4221

UKC02

NOMESCO Finland

Cystoscopy

1.5

79.3

3060

20881

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

79.2

2409

15564

U04

ICPC

Incontinence urine

2.1

79.1

917

4317

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

79.1

1560

8937

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

78.6

1271

6815

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

78.6

3777

26951

WX402

NOMESCO Finland

General anaesthesia

1.4

78.6

4079

29533

D07AA02

ATC

hydrocortisone; topical

1.5

78.5

3409

23840

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.5

78.4

2834

19055

UJD02

NOMESCO Finland

Gastroscopy

2.0

78.3

1058

5305

ZX120

NOMESCO Finland

Intravenous

1.6

77.9

2122

13328

C02EA02

ATC

2.3

77.5

759

3308

M09AX01

ATC

hyaluronic acid; parenteral

2.1

77.4

976

4761

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

77.3

1154

6009

212

Kela drug reimbursment

Gout

3.3

77.2

412

1248

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.2

77.1

835

3814

E50.9

ICD-10 Finland

Vitamin A deficiency, unspecified

749.9

76.9

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

76.6

530

1912

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.0

76.4

474

1595

C09DA07

ATC

telmisartan and diuretics; oral

2.1

76.2

926

4444

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

76.1

2032

12693

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

76.0

1095

5629

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.5

75.8

232

416

E61.2

ICD-10 Finland

Magnesium deficiency

66.8

75.8

X58

ICD-10 Finland

Exposure to other specified factors

1.5

75.2

3284

22979

R52.0

ICD-10 Finland

Acute pain

2.2

75.1

810

3694

WX892

NOMESCO Finland

Monitored bed care

1.7

75.1

1594

9334

N04BC05

ATC

pramipexole; oral

1.7

75.0

1522

8792

SPAT1059

SPAT

Spirometry at the office

1.9

74.9

1167

6170

-50

ICPC

Medication/prescr/renewal

2.0

74.2

961

4737

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

74.2

467

1587

R04.0

ICD-10 Finland

Epistaxis

1.8

74.0

1381

7771

R03BA08

ATC

ciclesonide; inhalant

1.6

73.8

1967

12281

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.1

73.7

430

1386

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

73.6

1114

5830

KGH10

NOMESCO Finland

Operation for phimosis

2.7

73.6

546

2052

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

73.5

1607

9492

L02

ICPC

Back symptom/complaint

1.6

73.3

2184

14023

D05AX52

ATC

calcipotriol, combinations; topical

1.8

73.1

1264

6936

N06AG02

ATC

moclobemide; oral

2.0

72.8

1040

5325

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

72.8

687

2940

D10

ICPC

Vomiting

1.7

72.8

1569

9228

A11CC03

ATC

alfacalcidol; systemic

2.7

72.2

534

2003

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.2

72.2

816

3796

R99

ICPC

Respiratory disease other

3.0

72.0

447

1504

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

72.0

2083

13276

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.8

71.9

1261

6948

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.7

71.7

1574

9308

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

71.6

939

4653

K77

ICPC

Heart failure

3.4

71.5

368

1085

R52.2

ICD-10 Finland

Other chronic pain

2.1

71.4

808

3761

N03AE01

ATC

clonazepam; systemic

1.8

71.4

1316

7371

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

71.4

2734

18598

L01

ICPC

Neck symptom/complaint

1.4

71.3

3257

22975

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

71.1

706

3095

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.9

71.1

1133

6040

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

71.1

832

3933

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

70.9

1072

5605

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

70.9

569

2237

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

70.8

1815

11205

RK320

NOMESCO Finland

4.6

70.8

257

557

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

70.7

665

2842

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

70.6

1358

7709

L30.4

ICD-10 Finland

Erythema intertrigo

3.5

70.6

343

967

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

70.4

2323

15282

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

70.2

626

2603

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

70.2

954

4795

J01DA06

ATC

[U] cefuroxime; systemic

1.4

70.2

3512

25208

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

69.9

660

2826

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

69.7

1132

6076

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.1

69.7

845

4053

L12

ICPC

Hand/finger symptom/complaint

1.4

69.6

3290

23353

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

69.6

1374

7866

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.4

69.5

262

590

L68.0

ICD-10 Finland

Hirsutism

4.8

69.5

243

507

104

Kela drug reimbursment

Thyroid insufficiency

1.7

69.4

1591

9521

S21

ICPC

Skin texture symptom/complaint

1.5

69.3

2711

18521

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

69.0

857

4153

N01

ICPC

Headache

1.5

69.0

2627

17839

C08DB01

ATC

diltiazem; oral

2.0

68.9

881

4320

R29

ICPC

Respiratory symptom/complaint other

1.7

68.9

1476

8664

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

68.9

2117

13687

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

68.8

587

2386

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

68.6

1061

5594

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

68.6

2171

14138

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

68.6

2505

16860

A10BD20

ATC

metformin and empagliflozin; systemic

3.8

68.5

303

790

N05BE01

ATC

buspirone; oral

2.2

68.5

725

3277

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.6

68.3

523

2005

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

68.2

758

3501

K86

ICPC

Hypertension uncomplicated

1.6

68.1

2137

13888

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

68.1

1209

6690

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.6

67.9

910

15380

C09BA03

ATC

lisinopril and diuretics; oral

2.7

67.7

496

1853

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

67.5

1351

7765

NG2AA

NOMESCO Finland

Patella X-ray examination

2.4

67.5

605

2523

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.2

67.5

369

1139

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

67.5

1166

6393

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

67.4

1546

9253

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

67.1

5418

42094

-1

NOMESCO Finland

1.3

67.1

8771

72726

K04.09

ICD-10 Finland

Pulpit UNS

1.9

67.0

1056

5609

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.5

66.8

558

2244

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

66.7

1599

9692

J01FA01

ATC

erythromycin; systemic

1.4

66.3

3672

26827

E03

ICD-10 Finland

Other hypothyroidism

1.8

66.3

1311

7509

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

66.2

704

3190

E87.6

ICD-10 Finland

Hypokalaemia

2.3

66.1

662

2917

S20

ICPC

Corn/callosity

2.8

66.1

443

1568

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

65.9

757

3549

TK800

NOMESCO Finland

Hemodialysis

2.6

65.9

508

1954

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

65.9

895

4496

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

65.9

3204

22849

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

65.8

1535

9230

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

65.8

605

2555

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

65.7

2062

13395

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

65.7

531

2098

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

65.6

550

2216

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

65.4

1435

8480

H25.8

ICD-10 Finland

Other senile cataract

1.6

65.4

1649

10131

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.5

65.3

555

2253

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

65.3

484

1820

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

65.2

526

2074

SPAT1360

SPAT

Extensive global examination

1.6

65.1

1606

9809

KMAK

NOMESCO Finland

1.2

65.0

14167

124380

T92

ICPC

Gout

3.0

64.8

400

1342

SPAT1251

SPAT

Organisation of medication

2.1

64.8

779

3723

D02AE01

ATC

carbamide; topical

1.7

64.7

1569

9539

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

64.6

499

1921

C10AA04

ATC

fluvastatin; oral

1.7

64.6

1507

9064

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.4

64.5

582

2434

RD250

NOMESCO Finland

+∞

64.2

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

64.2

2122

13951

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

64.0

556

2283

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.4

64.0

585

2465

K92.1

ICD-10 Finland

Melaena

1.9

63.8

951

4946

R21

ICPC

Throat symptom/complaint

1.3

63.7

5264

40992

A29

ICPC

General symptom/complaint other

1.5

63.7

2322

15606

R07.3

ICD-10 Finland

Other chest pain

1.6

63.6

1964

12707

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

63.6

413

1431

K80.8

ICD-10 Finland

Other cholelithiasis

2.9

63.5

409

1412

M15

ICD-10 Finland

Polyarthrosis

1.9

63.3

910

4673

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.3

62.9

617

2691

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

62.9

474

1801

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.0

62.8

829

4115

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

62.8

689

3164

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

62.8

334

1011

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.7

62.6

463

1738

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

62.5

924

4794

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

62.4

974

5151

D01AC03

ATC

econazole; topical

1.7

62.3

1295

7528

D07AB08

ATC

desonide; topical

1.5

62.2

2444

16692

N07BB01

ATC

disulfiram; oral

1.8

62.0

1034

5600

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

61.9

611

2673

Z72.0

ICD-10 Finland

Tobacco use

2.2

61.8

634

2825

R06AX22

ATC

ebastine; oral

1.4

61.7

4264

32296

G04BD08

ATC

solifenacin; oral

1.7

61.5

1263

7317

I20.09

ICD-10 Finland

Unstable angina

1.9

61.3

967

5137

C08CA05

ATC

nifedipine; systemic

1.7

61.1

1258

7288

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

60.9

763

3711

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.1

60.8

250

612

QBJ00

NOMESCO Finland

Liposuction in trunk

5.0

60.8

203

404

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

60.7

809

4035

C09DB01

ATC

valsartan and amlodipine; oral

2.2

60.6

665

3056

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

60.4

472

1828

J01FA15

ATC

telithromycin; oral

1.5

60.4

2409

16498

S22

ICPC

Nail symptom/complaint

1.7

60.4

1232

7123

A08AA01

ATC

phentermine; oral

6.5

60.3

162

247

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

60.2

1216

7006

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

60.2

1155

6550

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

60.2

1805

11592

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

60.1

369

1235

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

60.1

407

1449

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

60.0

790

3919

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

60.0

592

2590

M54.3

ICD-10 Finland

Sciatica

1.7

59.9

1305

7692

Z01.7

ICD-10 Finland

Laboratory examination

1.5

59.9

2478

17103

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

59.9

620

2774

M76.6

ICD-10 Finland

Achilles tendinitis

1.8

59.8

1026

5611

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

59.8

4578

35210

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

59.7

1104

6187

SPAT1151

SPAT

Treatment of major wounds

3.4

59.6

304

892

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

59.6

1033

5667

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

59.5

421

1541

E64.9

ICD-10 Finland

Sequelae of unspecified nutritional deficiency

581.2

59.4

J96.9

ICD-10 Finland

Respiratory failure, unspecified

5.8

59.3

173

294

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

59.2

1462

8929

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

59.1

468

1828

XF404

NOMESCO Finland

Ambulatory ECG

1.6

59.0

1859

12077

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.6

58.9

437

1643

A05

ICPC

Feeling ill

1.6

58.8

1450

8850

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.7

58.8

426

1583

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

58.6

1217

7069

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

58.6

895

4698

N05AE04

ATC

ziprasidone; systemic

4.0

58.6

242

595

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.4

58.6

294

852

E68

ICD-10 Finland

Sequelae of hyperalimentation

50.1

58.6

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

58.5

1219

7092

R06AX27

ATC

desloratadine; oral

1.3

58.4

7028

57465

C08CA10

ATC

nilvadipine; oral

2.7

58.3

418

1542

A08AA04

ATC

dexfenfluramine; oral

10.3

58.3

117

112

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.0

58.3

244

608

D09AB01

ATC

zinc bandage without supplements; topical

2.6

58.2

456

1772

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.7

58.2

1399

8478

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.6

58.0

446

1712

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.1

57.9

190

371

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

57.9

353

1176

L29

ICPC

Musculoskeletal sympt/complt other

1.6

57.8

1611

10153

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

57.7

2169

14663

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

57.6

922

4920

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

57.5

615

11046

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

57.1

599

2698

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

56.9

630

2907

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

56.4

2149

14565

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

56.4

1345

8136

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

56.0

3846

29055

A10BD08

ATC

metformin and vildagliptin; systemic

4.1

56.0

228

554

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

55.9

9999

85461

G04BD07

ATC

tolterodine; oral

1.9

55.9

914

4915

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

55.9

811

4175

SPAT1379

SPAT

Health check-up of pregnant person

1.4

55.8

2750

19627

UJF92

NOMESCO Finland

Capsular endoscopy

2.3

55.7

522

2228

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

55.7

910

4894

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

21.9

55.6

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

55.4

533

2305

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.9

55.4

355

1222

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

55.3

623

2897

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

55.2

2993

21730

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

55.1

1194

7024

R03BB01

ATC

ipratropium bromide; inhalant

2.1

55.1

644

3045

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.3

54.8

509

2163

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

54.8

579

2615

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

54.7

1554

9837

C10AB02

ATC

bezafibrate; oral

3.5

54.7

268

763

C07AB03

ATC

atenolol; systemic

1.8

54.6

1014

5689

Z00.0

ICD-10 Finland

General medical examination

1.3

54.6

4128

31647

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

54.4

665

3202

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

54.4

471

1932

SPAT1285

SPAT

Provision of consultation response

1.7

54.4

1154

6747

SPAT1172

SPAT

Guidance concerning hydration

2.6

54.2

410

1562

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.1

54.1

316

1024

E86

ICD-10 Finland

Volume depletion

2.5

54.1

436

1721

N07BA03

ATC

varenicline; oral

1.7

54.0

1227

7320

D01

ICPC

Abdominal pain/cramps general

1.4

53.8

2506

17690

SPAT1202

SPAT

Intra-articular injection

2.1

53.8

650

3113

SPAT1243

SPAT

Psychiatric/psychological examination

2.0

53.7

728

3654

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

53.7

3063

22431

C07AA05

ATC

propranolol; systemic

1.3

53.7

4675

36572

J01DC02

ATC

cefuroxime; systemic

1.6

53.3

1371

8460

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

53.2

651

3135

C10AA03

ATC

pravastatin; oral

1.7

53.2

1214

7248

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

53.1

426

1675

N06AX22

ATC

agomelatine; oral

2.2

53.1

562

2541

L11

ICPC

Wrist symptom/complaint

1.5

53.0

1798

11878

D82

ICPC

Teeth/gum disease

1.2

52.9

8901

75460

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

52.8

631

3008

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

52.7

460

8757

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.4

52.6

2847

20650

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.7

52.5

1179

7006

H36.01

ICD-10 Finland

Diabetic maculopathy

3.1

52.3

300

958

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.7

52.2

1095

6377

A10BD15

ATC

metformin and dapagliflozin; systemic

4.2

52.2

208

496

M01AB55

ATC

diclofenac, combinations; oral

1.6

52.2

1330

8188

S06

ICPC

Rash localized

1.7

52.1

1149

6795

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

51.9

797

4190

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

51.9

731

3722

RD160

NOMESCO Finland

8.6

51.9

115

132

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

6.7

51.8

136

202

R05DA01

ATC

ethylmorphine; oral

1.5

51.6

1752

11572

B80

ICPC

Iron deficiency anaemia

2.4

51.6

470

1977

D01AE15

ATC

terbinafine; topical

1.6

51.5

1394

8716

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

51.5

1545

9912

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.6

51.5

1401

8774

N06AA06

ATC

trimipramine; systemic

2.1

51.4

574

2660

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

51.3

405

1581

SPAT1284

SPAT

Extensive health certificate

2.0

51.3

703

3545

L84

ICD-10 Finland

Corns and callosities

2.0

51.2

698

3510

M54.1

ICD-10 Finland

Radiculopathy

1.8

51.2

854

4621

K03.66

ICD-10 Finland

Tooth plaque

1.6

51.2

1376

8586

A08AX01

ATC

rimonabant; oral

20.6

51.2

ULC02

NOMESCO Finland

Hysteroscopy

1.7

51.2

1181

7074

C07AB05

ATC

betaxolol; oral

2.3

51.1

494

2142

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.0

51.0

677

3371

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

51.0

1206

7273

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

50.9

1126

6661

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

50.9

555

2545

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

50.9

1148

6834

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.8

50.9

176

365

N05AH02

ATC

clozapine; systemic

2.3

50.9

488

2107

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

50.8

915

5080

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

50.8

1493

9531

O61.0

ICD-10 Finland

Failed medical induction of labour

3.0

50.8

302

991

I11

ICD-10 Finland

Hypertensive heart disease

5.6

50.7

153

272

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.1

50.7

613

2938

H60.8

ICD-10 Finland

Other otitis externa

2.1

50.6

620

2991

NHQ40

NOMESCO Finland

Amputation of toe

2.9

50.5

323

1113

N06AA10

ATC

nortriptyline; systemic

2.2

50.4

525

2356

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.0

50.2

306

1021

H3603, E113

ICD-10 Finland

3.8

50.2

221

577

JAG51

NOMESCO Finland

Laparoscopic repair of internal hernia

491.9

50.1

H60

ICD-10 Finland

Otitis externa

1.7

50.0

1057

6171

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.4

50.0

2331

16444

P74

ICPC

Anxiety disorder/anxiety state

1.8

50.0

932

5237

F32.8

ICD-10 Finland

Other depressive episodes

2.5

50.0

407

1617

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

49.8

914

5108

A12AA04

ATC

calcium carbonate; oral

2.7

49.8

347

1261

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.7

49.7

358

1326

A10BB07

ATC

glipizide; oral

3.6

49.6

232

637

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.5

49.5

417

1686

J01

ICD-10 Finland

Acute sinusitis

1.7

49.5

1172

7070

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

49.4

435

1802

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.3

49.3

189

435

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

49.2

2552

18362

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

49.2

471

2032

XF640

NOMESCO Finland

2.1

49.1

549

2543

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

49.1

332

1182

E000006

ATC

1.5

49.0

1540

9987

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.4

48.9

449

1896

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

48.8

677

3431

R10.0

ICD-10 Finland

Acute abdomen

1.9

48.8

712

3675

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.2

48.7

504

2258

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

48.7

1261

7796

C07FB02

ATC

metoprolol and felodipine; systemic

2.2

48.6

524

2391

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.6

48.6

366

1391

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.2

48.6

264

814

S17

ICPC

Abrasion/scratch/blister

2.3

48.5

484

2132

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

48.5

413

1679

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

48.5

1744

11665

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

48.5

310

1068

W19

ICD-10 Finland

Unspecified fall

1.5

48.4

1890

12868

D05AX02

ATC

calcipotriol; topical

1.8

48.3

818

4454

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

48.3

368

1409

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.6

48.2

375

1452

C09AA04

ATC

perindopril; oral

1.8

48.0

929

5281

R06AX13

ATC

loratadine; oral

1.3

48.0

3774

29044

SFA00

NOMESCO Finland

Small filling

1.4

48.0

2965

21982

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

48.0

586

2820

R31

ICD-10 Finland

Unspecified haematuria

1.5

48.0

1691

11260

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

47.9

471

2060

N17

ICPC

Vertigo/dizziness

1.4

47.8

2153

15082

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

47.8

2426

17383

H02AB09

ATC

hydrocortisone; systemic

2.2

47.7

524

2409

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

47.3

615

3038

S06.0

ICD-10 Finland

Concussion

1.4

47.3

2197

15482

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

47.2

513

2350

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

47.1

905

5134

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

47.0

1464

9474

M77.4

ICD-10 Finland

Metatarsalgia

1.6

47.0

1213

7489

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.8

47.0

810

4432

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

47.0

2185

15400

WX872

NOMESCO Finland

Intensive care

1.7

47.0

944

5430

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

46.9

1498

9750

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.6

46.9

1207

7447

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

46.9

817

4491

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

46.9

668

3421

M01AC01

ATC

piroxicam; systemic, rectal

1.4

46.8

2747

20185

JKA20

NOMESCO Finland

Cholecystectomy

2.2

46.7

499

2266

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.0

46.7

617

3068

CK2S4

SPAT

3.8

46.5

203

527

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

46.2

591

2902

N06AA04

ATC

clomipramine; systemic

2.4

46.1

405

1677

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

46.0

631

3181

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.4

46.0

406

1684

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

45.8

1179

7271

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

45.7

1523

10007

J01EA01

ATC

trimethoprim; systemic

1.3

45.7

5743

46974

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

45.6

1241

7766

Z08

ICPC

Social welfare problem

2.7

45.6

317

1152

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

45.5

656

3372

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

45.3

851

4792

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

8.2

45.2

103

124

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.7

45.2

974

5719

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

45.2

1084

6564

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.6

45.1

210

575

WX111

NOMESCO Finland

Local infiltration anesthesia

2.0

45.1

596

2963

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

44.8

1225

7676

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

44.7

950

5558

S01

ICPC

Pain/tenderness of skin

1.7

44.6

877

5008

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.5

44.5

351

1371

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.0

44.3

271

908

L30.3

ICD-10 Finland

Infective dermatitis

1.9

44.3

714

3823

EMB10

NOMESCO Finland

Tonsillectomy

1.5

44.3

1482

9753

N06AX18

ATC

reboxetine; oral

2.8

44.2

303

1090

R09

ICPC

Sinus symptom/complaint

1.5

44.2

1838

12671

C10AC01

ATC

colestyramine; oral

2.0

44.1

568

2798

R60.1

ICD-10 Finland

Generalized oedema

3.9

44.0

188

479

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

44.0

683

3607

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.6

43.9

338

1303

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

43.9

467

2121

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.6

43.8

338

1306

H60.3

ICD-10 Finland

Other infective otitis externa

2.1

43.8

501

2349

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.1

43.7

488

2263

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

43.7

706

3782

R35

ICD-10 Finland

Polyuria

1.6

43.7

1150

7138

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

43.5

853

4868

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.5

43.5

356

1419

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.1

43.5

541

2624

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

43.4

341

1328

N05AF01

ATC

flupentixol; systemic

2.4

43.4

377

1551

R4120

NOMESCO Finland

Occupational therapy

1.6

43.4

1320

8495

C07AB08

ATC

celiprolol; oral

2.2

43.4

453

2039

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

43.4

633

3269

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

43.3

1127

6972

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.9

43.2

640

3322

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

43.2

460

2090

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

43.1

1767

12146

A07AA02

ATC

nystatin; oral

1.6

43.1

1185

7437

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

43.1

4574

36619

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

43.0

490

2291

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.3

43.0

415

1799

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

42.9

1108

6841

N02AC04

ATC

dextropropoxyphene; oral

1.9

42.9

631

3268

G93.2

ICD-10 Finland

Benign intracranial hypertension

6.7

42.9

112

166

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.1

42.8

503

2383

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.4

42.8

1902

13284

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.1

42.8

484

2259

G03DB01

ATC

dydrogesterone; oral

1.3

42.7

3266

24997

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.1

42.6

502

2383

M54.8

ICD-10 Finland

Other dorsalgia

1.7

42.6

876

5073

S94

ICPC

Ingrowing nail

2.5

42.6

356

1436

E78.11

ICD-10 Finland

Other hypertriglyceridemia

4.4

42.5

158

354

N05AD01

ATC

haloperidol; systemic

2.0

42.4

566

2825

R5110

SPAT

2.1

42.4

496

2349

R51

ICD-10 Finland

Headache

1.6

42.3

1196

7560

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(1002224) Polysomnography panel

2640

11697

2.31

321.89

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

30802

272755

1.98

321.72

5.4

4.0

mmol/l

1.3

1.5

307.65

28919

254981

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

30941

274618

1.99

317.71

5.4

4.0

mmol/l

4.4

4.7

307.65

29208

257664

(3014111) Lactate [Moles/volume] in Serum or Plasma

3926

20414

1.99

316.19

8.9

7.1

mmol/l

1.4

1.3

8.30

3757

19732

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1569

5497

2.87

311.36

3.6

2.9

mmol/l

25.1

24.5

5.75

1401

4818

(3030467) Casts [#/volume] in Urine by Automated count

10302

70976

1.60

310.03

3.5

3.0

e6/l

0.5

0.4

4.26

7914

52605

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

30829

259103

2.55

307.65

6.2

4.6

mu/l

2.1

0.14

28972

240627

(3013115) Eosinophils [#/volume] in Blood

19368

142513

1.75

307.65

6.9

6.1

e9/l

0.2

28.21

17210

126234

(3024561) Albumin [Mass/volume] in Serum or Plasma

18729

107024

2.56

307.65

5.5

4.7

g/l

35.4

36.0

42.02

17684

99363

(3006315) Basophils [#/volume] in Blood

18852

137829

1.74

307.65

6.5

5.9

e9/l

0.0

5.05

16478

120224

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10903

75077

1.61

307.65

2.4

2.1

u/l

193.6

199.5

0.26

10255

70653

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

31359

278467

2.12

307.65

6.0

4.4

mmol/l

2.6

2.8

247.91

29488

259649

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

30791

246157

3.09

307.65

8.9

4.9

mmol/mol

42.6

38.7

307.65

29264

229726

(3013650) Neutrophils [#/volume] in Blood by Automated count

20770

158629

1.70

307.65

9.5

8.9

e9/l

4.6

4.0

221.73

18319

139242

(3032080) INR in Blood by Coagulation assay

15355

97038

1.99

307.65

10.1

7.5

inr

1.2

1.57

4375

29241

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

30124

262992

1.95

307.65

4.9

3.6

mmol/l

1.6

1.3

307.65

28096

244773

(3031040) Bacteria [#/volume] in Urine by Automated count

22917

181276

1.70

307.65

5.3

4.1

e6/l

1347.9

1414.1

0.07

372

2253

(3018418) pH of Serum or Plasma

11269

73368

1.74

307.65

4.9

4.0

7.4

0.76

2162

13947

(3019309) Folate [Moles/volume] in Red Blood Cells

8713

40808

2.45

307.65

2.1

1.7

nmol/l

1210.8

1160.0

5.48

7075

30932

(3009508) Creatinine [Moles/volume] in Urine

15263

75374

2.76

307.65

3.7

3.2

mmol/l

7.9

0.04

12911

64065

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

31825

282037

2.35

307.65

20.2

12.2

mg/l

21.5

22.2

3.91

28731

217914

(3019069) Monocytes/100 leukocytes in Blood

17625

129649

1.67

307.65

7.0

6.2

8.1

8.4

46.43

16618

121948

(3009343) pH of Capillary blood

4099

13587

3.21

307.65

3.9

3.5

7.4

5.20

456

1842

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5487

24123

2.45

307.65

2.1

2.2

nmol/l

344.3

379.1

30.57

4981

22340

(3016244) Insulin [Units/volume] in Serum or Plasma

1187

1346

8.89

307.65

4.2

2.6

mu/l

41.7

17.2

42.91

1139

1252

(3026782) Osmolality of Urine

7841

49062

1.73

307.65

3.2

2.6

mosm/kgh2o

561.7

541.9

9.37

6735

41729

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1052

2606

4.04

307.65

1.2

1.3

nmol/l

27.0

28.8

0.10

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7447

35294

2.35

307.65

3.0

2.4

g/l

2.5

2.4

38.85

6898

32713

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13064

82362

1.89

307.65

2.9

2.5

u/l

50.7

58.6

18.09

12115

76102

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17425

111847

2.06

307.65

7.6

5.7

mmol/l

1.2

25.99

16067

101598

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8623

38602

2.58

307.65

3.5

mmol/l

0.8

0.20

8157

36048

(3020779) Urea [Moles/volume] in Serum or Plasma

4265

20199

2.21

307.65

9.3

7.7

mmol/l

10.8

8.9

46.18

4066

19326

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1602

5188

3.12

307.65

2.4

ug/min

140.5

103.1

2.01

998

3133

(3019198) Lymphocytes [#/volume] in Blood

19184

141994

1.72

307.65

6.6

5.8

e9/l

2.0

1.9

6.37

17104

126193

(3002582) Erythrocytes [#/volume] in Urine

11231

77540

1.62

307.65

3.7

3.1

e6/l

73.5

82.7

0.30

8799

58680

(3015377) Calcium [Moles/volume] in Serum or Plasma

12869

85264

1.76

307.65

3.1

3.4

mmol/l

2.3

2.4

21.75

11312

75271

(3013512) EKG study

10789

69540

1.75

307.65

4.7

3.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

32266

282658

2.82

307.65

23.3

13.5

mmol/l

4.0

3.9

30.23

31732

274915

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19127

123666

2.15

307.65

8.3

6.4

mmol/l

1.2

28.63

16439

104504

(3022948) Iron [Moles/volume] in Serum or Plasma

7956

38608

2.32

307.65

3.0

2.4

umol/l

12.5

14.3

3.09

7420

35874

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14736

89646

2.06

307.65

3.5

3.2

u/l

32.8

32.6

0.13

13983

85223

(3006504) Eosinophils/100 leukocytes in Blood

17531

128955

1.67

307.65

6.7

6.0

2.8

3.04

16431

120561

(3012544) pH of Venous blood

4597

21628

2.24

307.65

4.8

4.0

7.4

0.08

105

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3971

13119

3.21

307.65

3.8

3.4

mmol/l

1.8

1.6

3.19

2994

9559

(3021960) Folate [Moles/volume] in Serum or Plasma

10304

54098

2.23

307.65

1.8

1.5

nmol/l

20.2

20.4

0.55

9169

46661

(3042936) Bacteria identified in Isolate by Culture

6565

35439

2.00

307.65

2.4

1.9

—

(3016502) Oxygen saturation in Arterial blood

4610

22998

2.11

307.65

9.1

7.8

94.7

96.0

37.49

4470

22115

(3019060) Gas panel - Arterial blood

3216

14380

2.31

307.65

5.2

4.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

5882

28697

2.21

307.65

8.1

7.3

mmol/l

104.3

104.5

4.48

5757

28108

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

13362

91773

1.69

307.65

3.8

3.2

—

0.2

—

(3022313) Gas panel - Capillary blood

3106

9642

3.36

307.65

3.9

3.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

5163

25741

2.13

307.65

8.7

7.4

kpa

11.1

13.0

160.45

4946

24597

(3013707) Erythrocyte sedimentation rate by Westergren method

25076

204352

1.73

307.65

4.8

3.9

mm/h

15.5

10.7

307.65

23395

190537

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2663

8599

3.20

307.65

4.0

3.8

mmol/l

24.8

24.7

0.97

2499

7974

(3002032) Base excess in Venous blood by calculation

4443

20837

2.24

307.65

4.8

4.0

mmol/l

2.0

1.8

3.21

3700

17051

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4484

20875

2.26

307.65

4.8

4.0

kpa

6.0

5.8

17.07

4358

20273

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5165

25757

2.13

307.65

8.7

7.4

kpa

5.3

5.0

53.60

4963

24617

(3001604) Monocytes [#/volume] in Blood

18753

137248

1.74

307.65

6.5

5.8

e9/l

0.6

63.39

16430

119777

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4129

13775

3.19

307.65

3.9

3.5

kpa

5.3

5.1

32.50

3861

12734

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

23972

192481

1.71

307.65

4.1

2.9

u/l

56.9

43.1

79.46

22564

181618

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13900

92028

1.80

307.65

4.4

3.1

ng/l

51.4

61.4

0.46

9139

55556

(3022096) Basophils/100 leukocytes in Blood

16971

124908

1.65

307.65

6.7

6.1

0.6

0.7

32.94

15906

116826

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9757

64403

1.67

307.65

2.5

2.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

22891

151900

2.41

307.65

6.3

4.4

mmol/l

7.1

6.5

214.95

21452

140126

(3022217) INR in Platelet poor plasma by Coagulation assay

5180

28731

1.90

307.65

24.9

20.5

inr

1.3

0.88

666

4350

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1542

4620

3.37

307.65

1.9

2.2

nmol/l

1.1

0.8

23.97

1229

3938

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6960

32396

2.38

307.65

3.1

2.5

20.9

23.6

50.02

6085

27775

(3002030) Lymphocytes/100 leukocytes in Blood

17968

134053

1.65

307.65

6.8

6.0

27.2

28.8

81.26

16870

125486

(3019550) Sodium [Moles/volume] in Serum or Plasma

32241

281779

2.84

307.65

23.1

13.4

mmol/l

139.7

139.6

0.77

31750

274600

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

30885

265335

2.33

307.65

6.1

4.0

mmol/l

6.4

5.8

307.65

28857

245363

(3000991) Gas panel - Venous blood

3894

19591

2.06

307.65

10.2

8.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3658

17288

2.19

307.65

4.6

3.8

ng/l

102.3

85.4

16.68

3181

15157

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6635

38133

1.87

307.65

2.0

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

12743

66439

2.39

307.65

2.9

2.4

umol/l

3652.0

3662.5

0.01

11171

58411

(42870588) Differential panel, method unspecified - Blood

13333

91517

1.69

307.65

6.2

6.0

—

(40768797) Stomach Pathology biopsy report

6194

35736

1.85

307.65

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18830

127337

1.98

307.65

4.0

2.8

ug/l

108.0

110.0

0.58

17722

119270

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11935

62368

2.33

307.65

2.7

2.1

mg/l

3.2

2.8

49.96

10572

53309

(3003396) Base excess in Arterial blood by calculation

5159

25749

2.13

307.65

8.7

7.4

mmol/l

1.4

0.9

11.54

4188

20148

(3018095) Leukocytes [#/volume] in Urine

12953

93197

1.57

307.65

4.3

3.5

e6/l

85.7

83.2

0.14

9406

63832

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7734

29615

3.00

307.65

6.2

6.0

mmol/l

1.1

1.0

29.25

7357

27708

(3026008) Bacteria identified in Urine by Culture

11867

75823

1.81

307.65

3.4

2.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11859

60595

2.39

307.65

3.5

2.8

ng/l

1239.0

1157.3

1.16

9824

51318

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10090

59788

1.92

307.65

2.0

1.7

mg/l

1.0

1.1

1.73

7850

44984

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4832

22493

2.28

307.65

2.4

2.3

g/l

0.2

0.93

4498

21046

(3024354) Oxygen [Partial pressure] in Venous blood

3689

17003

2.25

307.65

4.1

3.3

kpa

4.8

4.6

2.92

3568

16452

(3037467) Urinalysis macro (dipstick) panel - Urine

24142

190778

1.79

307.65

5.1

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

12947

84883

1.79

307.65

2.6

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

15073

70478

2.94

307.65

4.7

3.9

mg/mmol

11.7

9.0

7.38

10392

44001

(3033658) Prothrombin time (PT) actual/Normal

10035

66643

1.66

307.65

4.6

3.8

92.6

0.03

9733

64908

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9434

51458

2.09

307.65

2.0

1.6

pmol/l

31569573.8

37767118.1

0.46

8068

43263

(3007853) Bacteria identified in Skin by Aerobe culture

6152

30513

2.18

307.65

2.0

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17374

99750

2.42

307.65

2.5

1.8

pmol/l

94.7

97.6

13.30

10444

51814

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18061

130490

1.74

307.65

4.5

3.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

27667

219668

2.17

307.65

5.1

4.0

pmol/l

14.6

0.14

25712

202106

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

27149

205454

2.37

307.65

8.5

7.2

u/l

81.4

76.1

63.23

25933

193664

(3018010) Neutrophils/100 leukocytes in Blood

17744

132140

1.64

307.65

6.6

5.8

58.6

56.6

101.17

16700

124213

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5981

34203

1.86

307.65

1.9

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20157

134534

2.12

307.65

6.0

umol/l

10.7

11.0

2.69

19107

127268

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18032

109773

2.27

307.65

3.1

2.2

nmol/l

70.5

895.7

0.50

16711

100136

(3012516) Albumin [Mass/volume] in Urine

14341

67242

2.86

307.65

3.7

3.2

mg/l

240.6

452.2

9.73

9927

41774

(3023368) Bacteria identified in Blood by Culture

11139

63206

2.07

307.65

4.9

4.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4052

21539

1.95

305.45

9.9

8.2

g/l

124.3

121.6

12.19

3947

20745

(3035350) Ketones [Presence] in Urine by Test strip

17539

136284

1.52

305.35

4.3

3.3

estimate

0.0

2.75

3547

25566

(3015736) pH of Urine

14158

105156

1.54

303.78

3.9

3.1

5.8

0.03

(3009261) Glucose [Presence] in Urine by Test strip

17695

138075

1.52

299.68

4.4

3.4

estimate

0.0

0.70

3416

25690

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

29689

261041

1.81

299.41

17.7

11.1

ml/min/173m2

85.7

85.4

0.99

25374

213871

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1340

4398

3.06

298.70

3.5

3.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2834

13348

2.17

296.83

4.2

3.4

g/l

130.0

129.6

0.36

2764

13036

(3027273) Bicarbonate [Moles/volume] in Venous blood

2353

10283

2.33

295.44

4.2

3.3

mmol/l

25.4

25.2

1.46

2289

9964

(3021601) Nitrite [Presence] in Urine by Test strip

17508

136774

1.51

291.52

5.8

4.5

estimate

0.0

0.47

3676

26271

(3027945) Reticulocytes/100 erythrocytes in Blood

4511

25323

1.85

286.36

2.6

2.0

1.7

32.01

3967

22595

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2200

9479

2.35

285.11

5.0

3.7

50.4

48.8

2.32

2171

9379

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

295

252

11.53

282.02

1.0

1.1

ug/l

71.7

91.5

7.83

261

198

(3000850) Epithelial cells [#/volume] in Urine

8038

53483

1.61

273.35

3.0

2.5

e6/l

7.4

6.0

12.55

7020

46549

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9887

69093

1.56

272.08

1.7

1.6

mmol/l

1.7

1.3

135.91

8341

58812

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5040

29887

1.76

264.70

2.9

2.7

umol/l

8.1

8.0

0.08

4258

25775

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2526

11882

2.16

264.30

11.0

9.7

mmol/l

24.7

24.2

8.51

2340

11168

(3021589) Normoblasts [#/volume] in Blood

15808

122712

1.48

259.52

11.5

8.9

e9/l

0.0

2.81

13043

100894

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4472

25749

1.80

259.31

1.9

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5837

36290

1.69

257.53

1.9

1.7

1.5

1.4

7.22

5104

32304

(4146454)

808

2131

3.77

254.37

2.7

2.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4472

25926

1.79

252.90

1.9

1.7

—

(36304419) Bacteria [Presence] in Urine

9891

70016

1.53

252.82

3.5

2.9

—

(3037522) Nuclear Ab [Titer] in Serum

6218

39668

1.65

247.24

1.4

titre

483.1

554.6

2.30

1163

8031

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

769

2006

3.81

245.92

1.5

1.3

nmol/l

1.7

1.4

11.74

710

1796

(3044889) 12 lead EKG panel

22208

185386

1.48

244.24

4.3

3.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2187

10067

2.20

240.95

3.7

3.0

0.7

0.22

2109

9643

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

32628

299408

2.23

240.88

13.5

9.5

u/l

30.2

25.9

177.08

31872

289899

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2223

10308

2.18

240.45

3.7

3.0

1.4

1.3

5.42

2211

10255

(3020564) Creatinine [Moles/volume] in Serum or Plasma

32477

297552

2.16

239.63

22.5

13.8

umol/l

77.9

73.8

50.41

32471

297416

(3028626) Oxygen [Partial pressure] in Capillary blood

1392

5278

2.64

236.34

3.6

3.2

kpa

8.3

8.6

7.24

1310

4895

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3308

17826

1.90

235.74

3.1

2.7

ng/l

173.3

172.2

0.05

2931

16184

(3021901) Oxygen saturation in Capillary blood

1148

3949

2.90

234.79

3.2

2.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3248

17493

1.90

231.65

1.7

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1153

4030

2.86

228.94

1.1

iu/ml

43.4

2989.1

0.67

257

942

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2328

11321

2.08

222.06

5.2

4.5

mmol/l

24.2

24.1

0.58

2064

10225

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4950

30570

1.68

220.57

5.2

4.1

29.8

32.5

60.22

3861

21370

(3007164) IgA [Mass/volume] in Serum or Plasma

8180

56964

1.53

219.64

1.5

1.4

g/l

2.6

2.3

25.38

5029

35420

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2765

14354

1.96

219.62

11.2

9.4

0.7

3.93

2744

14277

(3014007) Fractional oxyhemoglobin in Arterial blood

2775

14448

1.95

218.49

11.2

9.4

93.1

94.2

16.71

2763

14398

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2765

14381

1.96

218.36

11.1

9.3

1.5

1.4

3.80

2742

14297

(3019225) pH of Specimen

4029

23653

1.75

215.65

4.7

4.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2705

14043

1.96

214.63

8.5

7.1

mmol/l

25.0

24.5

8.02

2555

13057

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2779

14748

1.91

206.20

8.7

7.2

mmol/l

25.1

24.7

5.95

2755

14631

(3023520) Reticulocytes [#/volume] in Blood

3301

18518

1.82

205.59

2.6

e9/l

79.0

69.1

34.75

2474

13849

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2697

14215

1.93

204.21

1.7

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9168

66227

1.48

203.20

1.3

u/ml

1.5

1.6

0.36

2487

18390

(1616796) Gas panel - Central venous blood

1309

5195

2.52

201.91

4.8

3.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3273

18411

1.81

201.82

2.1

2.6

g/l

66.6

66.7

0.25

2980

16893

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1840

8471

2.19

201.74

2.3

2.0

ug/l

2.1

0.11

1637

7498

(40758558) Short blood count panel - Blood

9393

68675

1.46

193.89

7.0

6.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2513

13229

1.92

190.47

1.8

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6493

44193

1.54

189.61

2.8

2.9

mmol/l

2.4

2.91

5554

38767

(3028026) IgM [Mass/volume] in Serum or Plasma

2843

15613

1.85

188.93

1.7

1.9

g/l

1.2

1.3

8.37

2595

14332

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4381

27202

1.66

188.70

3.5

4.3

u/l

237.0

240.2

0.64

4128

25838

(3034770) Mitochondria Ab [Titer] in Serum

1619

7312

2.22

185.85

1.2

titre

1016.4

930.0

0.17

224

(3020891) Body temperature

1868

8933

2.10

185.38

5.7

4.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13510

106115

1.40

185.22

4.6

3.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

504

1189

4.19

185.04

1.9

1.5

nmol/l

1.6

1.1

10.41

394

939

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1588

7133

2.23

184.72

3.5

3.3

u/ml

0.3

0.10

920

4017

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6771

46808

1.51

182.97

4.2

3.4

ng/l

338.1

519.7

2.70

4868

32970

(40761511) CBC panel - Blood by Automated count

32150

296651

1.88

182.79

19.1

11.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6346

43382

1.53

180.43

2.9

2.6

e6/l

1.3

1.1

1.73

3625

24224

(3005719) IgG [Mass/volume] in Serum or Plasma

3460

20430

1.73

179.32

2.4

2.7

g/l

10.6

10.5

0.29

3159

18773

(3007566) Smooth muscle Ab [Titer] in Serum

1616

7434

2.18

177.05

1.2

1.3

titre

119.9

124.5

0.08

153

685

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3208

18664

1.75

175.02

3.1

3.4

pmol/l

4.5

2.40

2811

16785

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5956

40460

1.53

173.56

3.1

2.8

e6/l

4.9

3.0

7.63

3254

21458

(3029937) Albumin [Presence] in Urine by Test strip

9712

73055

1.42

166.28

4.9

3.7

estimate

0.0

0.44

3475

25486

(4010399)

3163

18619

1.73

165.00

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6764

47676

1.48

163.65

1.3

u/ml

9.5

11.3

1.50

2594

19172

(3018405) Lactate [Moles/volume] in Arterial blood

1632

7770

2.10

163.43

4.6

4.3

mmol/l

1.4

1.78

1599

7637

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5583

37979

1.52

160.15

2.3

2.2

30.2

29.6

9.07

5400

36872

(3000494) Fungus identified in Specimen by Culture

4749

31194

1.57

159.74

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7489

54085

1.45

159.11

1.8

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7064

50460

1.46

158.94

1.3

iu/ml

35.1

33.3

0.16

1974

15872

(3017143) Hepatitis C virus Ab [Presence] in Serum

5392

36567

1.52

156.54

1.7

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1973

10221

1.94

155.91

1.8

g/l

1.6

1.5

10.06

1690

8804

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1387

6311

2.20

155.87

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1159

4919

2.35

153.78

3.5

2.7

umol/l

35.8

33.8

1.79

1000

4189

(3010421) pH of Blood

1360

6227

2.18

150.39

5.5

3.6

7.4

7.26

1198

5251

(3004588) Protein electrophoresis panel - Serum or Plasma

2615

14963

1.77

150.13

1.9

2.3

—

(3027315) Oxygen [Partial pressure] in Blood

1227

5394

2.27

149.90

5.6

3.6

kpa

8.6

8.8

4.35

1203

5279

(3013290) Carbon dioxide [Partial pressure] in Blood

1221

5362

2.27

149.54

5.6

3.6

kpa

5.2

5.0

15.53

1197

5248

(3012501) Base excess in Blood by calculation

1220

5361

2.27

149.19

5.5

3.6

mmol/l

3.0

2.4

7.66

851

3536

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3852

24505

1.60

147.72

2.7

2.5

u/l

51.5

44.3

0.22

3200

21088

(3009214) Lutropin [Units/volume] in Serum or Plasma

1813

9354

1.94

144.74

1.4

1.3

u/l

8.6

10.5

10.08

1481

7671

(3008037) Lactate [Moles/volume] in Venous blood

1052

4440

2.36

141.27

3.9

2.9

mmol/l

1.6

1.5

2.49

1033

4336

(3013139) Helicobacter pylori Ag [Presence] in Stool

3066

18631

1.67

140.92

1.2

—

(3037121) Protein [Mass/volume] in Urine

1647

8307

1.98

140.37

2.9

3.3

g/l

0.4

0.3

1.41

787

3679

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3227

19901

1.64

139.96

4.9

3.7

mmol/l

1.2

18.51

2863

17373

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3845

24892

1.57

136.08

4.1

3.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2060

11303

1.83

135.68

2.0

1.6

mg/l

5.0

3.2

7.91

1857

7480

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1179

5312

2.21

135.55

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

8389

63312

1.39

135.11

4.2

3.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

159

162

9.63

134.64

2.2

1.8

umol/l

1.3

0.22

153

138

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1760

9208

1.91

134.56

5.8

4.9

1.8

1.7

2.02

1677

8591

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1997

10947

1.83

131.83

1.5

u/ml

11.8

12.8

0.15

300

(3019150) Specific gravity of Urine by Refractometry

7858

58942

1.39

130.49

4.7

3.6

kg/l

1.0

0.13

1172

8899

(3038515) Glucose [Moles/volume] in Venous blood

982

4168

2.34

130.11

4.1

3.0

mmol/l

7.9

7.4

4.18

965

4083

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1170

5368

2.17

128.48

2.5

2.1

g/l

131.4

131.0

0.23

874

3882

(40767503) Oxygen content in Capillary blood by calculation

1096

4953

2.20

124.97

3.2

2.4

16.5

16.6

0.30

641

2491

(3043409) Potassium [Moles/volume] in Arterial blood

1367

6729

2.03

124.54

5.1

4.5

mmol/l

3.9

2.04

1273

6351

(3007930) Methemoglobin/Hemoglobin.total in Blood

1705

9059

1.88

124.12

6.0

5.0

0.9

6.76

1628

8460

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

942

4033

2.32

122.29

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2187

12686

1.73

118.67

12.8

9.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

414

1186

3.44

115.06

1.7

1.6

nmol/l

3.1

9.8

0.76

341

982

(3011985) Renin [Units/volume] in Plasma

832

3475

2.37

114.28

1.5

1.6

mu/l

81.5

65.9

1.06

734

3115

(3021387) Prolactin [Units/volume] in Serum or Plasma

2163

12667

1.71

113.22

1.7

1.6

mu/l

302.0

312.8

0.73

1933

11405

(40760892) CBC W Ordered Manual Differential panel - Blood

8362

64583

1.35

112.53

4.9

4.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1611

8676

1.85

112.18

1.6

titre

176.9

311.4

1.84

345

(3028717) Thiamine [Mass/volume] in Blood

155

193

7.88

112.17

1.4

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

516

1719

2.96

111.54

1.3

umol/l

5.4

5.1

0.79

477

1588

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1819

10195

1.78

111.08

2.1

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

776

3183

2.41

110.99

3.2

3.0

nmol/l

0.8

0.01

606

2402

(3017181) Myelocytes/100 leukocytes in Blood

3368

22127

1.54

110.13

4.4

4.1

0.9

0.16

1002

5865

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2971

18990

1.58

109.73

2.5

2.2

ug/l

6.0

7.7

5.24

2503

16756

(3021440) Promyelocytes/100 leukocytes in Blood

3226

21074

1.55

108.13

4.4

4.1

0.1

0.03

944

5417

(1761482) Bacteria [#/volume] in Urine by Culture

1139

5532

2.05

107.51

4.4

3.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

9615

76227

1.32

107.12

4.0

3.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1515

8124

1.86

106.86

2.4

2.3

ug/l

591.2

513.2

0.19

1418

7525

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7930

61185

1.35

106.32

1.8

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1665

9254

1.80

104.45

2.0

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

261

579

4.43

103.91

1.7

1.2

umol/l

17.4

16.9

0.70

237

510

(3024928) Oxygen saturation in Venous blood

1023

4841

2.10

103.53

4.1

3.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1255

6417

1.95

102.31

2.3

3.4

ratio

2.5

3.7

0.44

515

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1283

6613

1.93

102.13

2.3

3.5

mg/l

38.7

41.4

0.42

979

5385

(3034860) Kappa light chains.free [Mass/volume] in Serum

1284

6624

1.93

101.94

2.3

3.5

mg/l

56.9

58.0

0.04

987

5391

(3035285) Chloride [Moles/volume] in Venous blood

622

2401

2.56

101.32

2.8

2.2

mmol/l

105.7

0.06

617

2380

(3041354) Potassium [Moles/volume] in Venous blood

622

2403

2.56

101.14

2.8

2.2

mmol/l

4.1

4.0

1.12

617

2382

(46235355) HIV 1 and 2 tests - Meaningful Use set

8308

64937

1.33

101.04

2.0

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

613

2354

2.57

100.93

2.8

2.2

—

(40761535) Cells panel - Urine sediment

3088

20302

1.53

100.11

4.0

3.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2520

15851

1.60

99.22

2.5

2.2

u/l

5621.1

6200.8

0.47

967

6466

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1090

5366

2.02

99.04

1.4

1.3

u/l

17.4

26.9

27.18

888

4440

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

752

3218

2.31

97.67

1.4

pmol/l

320.4

315.2

0.08

611

2485

(3002179) Metamyelocytes/100 leukocytes in Blood

3061

20206

1.53

97.24

4.0

3.9

0.6

0.7

0.73

722

4267

(3048689) Calprotectin [Mass/mass] in Stool

5090

37061

1.40

96.85

2.4

ug/g

140.1

123.7

2.59

4035

29062

(3005322) IgE [Units/volume] in Serum or Plasma

2909

19125

1.53

94.01

1.3

u/ml

271.1

228.0

0.82

2713

17730

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

995

4831

2.04

93.91

1.2

titre

100.0

141.9

0.39

105

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1810

10686

1.69

91.43

1.5

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1296

6979

1.85

89.98

1.4

1.5

iu/ml

15.7

14.5

0.08

158

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1342

7314

1.82

89.62

1.4

ug/g

285.9

279.0

0.55

740

4158

(3025159) Blasts/100 leukocytes in Blood

2998

20049

1.50

89.15

4.5

4.2

0.1

0.2

2.44

796

4607

(3004775) Volume in Urine collected for unspecified duration

473

1702

2.74

88.69

2.3

731.7

660.4

2.23

325

1201

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1359

7464

1.81

88.47

1.9

1.7

nmol/l

33.4

43.8

38.73

1315

7288

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

694

3014

2.28

87.05

7.3

6.3

mg/l

11.4

0.05

635

2778

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1890

11436

1.65

86.77

2.0

u/l

38.6

39.4

0.99

1675

10296

(3020876) Protein [Mass/time] in 24 hour Urine

502

1886

2.62

86.46

1.9

2.0

g/24h

1.3

1.0

0.48

107

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2083

12934

1.61

86.15

3.0

2.6

e6/l

0.4

0.3

2.41

2036

12514

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1307

7161

1.81

85.74

2.0

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1270

6902

1.83

85.56

3.8

3.9

mg/l

1.8

1.4

34.22

1159

6424

(3035637) Corticotropin [Mass/volume] in Plasma

737

3310

2.20

85.22

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

563

2257

2.46

84.68

1.9

2.2

nmol/l

18.9

19.4

0.60

523

2156

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2758

18415

1.50

82.33

2.8

2.1

nmol/l

9.0

12.3

75.45

2405

16440

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

631

2698

2.31

82.12

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3204

22099

1.46

81.18

1.2

iu/ml

134.6

146.2

0.73

1162

8522

(3025941) Bacteria identified in Stool by Culture

2529

16646

1.52

80.75

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4235

30755

1.39

80.45

8.0

6.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

612

2609

2.32

80.20

9.3

8.1

mmol/l

8.3

7.1

2.75

508

2119

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1175

6365

1.83

79.95

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

748

3478

2.13

79.21

1.2

1.3

u/l

36.1

34.0

0.12

641

3048

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1478

8626

1.70

77.69

1.6

1.8

g/l

0.3

0.2

29.60

1405

8185

(3000330) Specific gravity of Urine by Test strip

1931

12087

1.59

76.99

3.9

3.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

968

4988

1.92

76.96

2.3

3.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

784

3754

2.06

76.81

2.4

1.8

mmol/l

1.8

1.7

0.69

769

3665

(3000492) Spirometry study

3819

27486

1.40

76.18

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

965

4985

1.92

76.15

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

964

4983

1.92

75.92

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

10289

85108

1.26

75.90

1.6

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

382

1344

2.80

74.83

1.8

1.4

umol/l

16.5

27.4

14.50

366

1279

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

761

3643

2.06

74.61

1.2

1.3

nmol/l

0.1

0.3

2.61

224

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

879

4431

1.96

74.56

1.8

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

971

5083

1.89

73.58

2.1

1.8

pmol/l

152.6

191.9

24.93

901

4846

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

448

1729

2.55

73.09

13.3

11.8

mmol/l

0.6

0.38

407

1592

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

744

3562

2.06

72.92

1.1

g/l

1.5

0.43

663

3250

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

759

3663

2.05

72.79

1.2

1.3

nmol/l

1.1

1.3

0.10

730

3524

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1497

8922

1.67

72.65

1.6

1.8

g/l

1.3

1.2

70.54

1429

8493

(3000475) Leukocytes [#/volume] in Synovial fluid

1072

5829

1.82

72.00

1.8

1.6

e6/l

14376.0

12407.0

0.64

766

4270

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

700

3292

2.10

71.96

1.2

1.3

—

(3022145) Colonoscopy Study observation

4118

30295

1.37

71.62

1.4

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1433

8496

1.68

70.92

1.9

2.2

g/l

7.8

7.3

19.14

1043

6462

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1430

8476

1.68

70.84

1.9

2.2

g/l

4.1

3.8

13.08

1005

6144

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1431

8485

1.68

70.80

1.9

2.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

946

5001

1.87

69.52

1.5

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

194

472

4.03

68.58

1.4

1.5

nmol/l

7.8

5.6

0.55

184

450

(3007461) Platelets [#/volume] in Blood

33257

317300

1.70

68.34

30.0

18.0

e9/l

263.2

255.8

77.92

32741

309804

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1037

5673

1.81

68.25

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1300

7633

1.69

66.70

3.2

3.0

—

(3017569) Oxygen content in Arterial blood

286

918

3.06

66.17

2.0

2.2

—

(3035941) MCH [Entitic mass]

33263

317531

1.68

66.05

29.8

17.9

29.8

30.3

307.65

32980

313755

(21494755) Public health laboratory ask at order entry panel

2527

34527

0.69

65.74

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

650

3079

2.08

65.57

2.3

1.7

89.1

90.3

5.19

640

3034

(3024731) MCV [Entitic volume]

33263

317576

1.68

65.41

29.9

17.9

90.1

90.7

106.50

32981

313787

(3028707) Methadone [Presence] in Urine by Screen method

1025

5663

1.79

65.27

2.6

2.8

—

(3026361) Erythrocytes [#/volume] in Blood

33264

317601

1.68

65.22

30.0

18.0

e12/l

4.6

4.5

65.15

32685

309346

(3017732) Neutrophils [#/volume] in Blood

2788

19483

1.43

65.13

3.0

2.6

e9/l

4.5

4.0

17.35

2121

15542

(3010813) Leukocytes [#/volume] in Blood

33266

317669

1.67

64.59

30.0

18.0

e9/l

7.4

6.6

307.65

32679

309369

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1329

7924

1.66

64.30

1.9

2.2

g/l

10.2

0.01

1127

6683

(3000963) Hemoglobin [Mass/volume] in Blood

33268

317717

1.67

64.25

30.2

18.1

g/l

134.6

135.6

28.21

32999

313965

(3016750) Collection duration of Urine

352

1287

2.69

64.11

2.1

2.2

min

497.3

500.1

0.19

252

992

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

302

1030

2.88

62.76

2.0

2.1

ug/min

181.3

82.7

0.58

225

(3009466) Valproate [Moles/volume] in Serum or Plasma

746

3780

1.95

62.34

6.1

5.1

umol/l

359.0

374.2

2.01

655

3286

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1384

8409

1.63

62.15

2.6

2.7

g/l

4.0

3.5

18.93

1312

8016

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1518

9485

1.59

60.71

2.1

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1019

5763

1.75

59.86

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

758

3919

1.91

59.66

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1324

8053

1.63

59.17

1.9

2.3

g/l

3.2

3.0

4.63

1030

6321

(40768441) Liver Pathology biopsy report

437

1857

2.32

57.80

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

420

1757

2.35

57.60

18.6

17.8

nmol/l

3190.0

1988.9

0.30

403

1682

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

462

2015

2.26

57.47

1.1

mg/l

293.3

291.4

0.21

397

1833

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

604

2928

2.03

57.27

2.2

2.0

mg/l

24.0

25.4

0.28

194

768

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1215

7294

1.65

57.18

2.2

2.1

mg/l

11.0

10.7

0.69

1127

6837

(3013005) Retinol [Moles/volume] in Serum or Plasma

317

1167

2.67

57.02

2.0

1.8

umol/l

1.9

2.0

1.73

301

1089

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

404

1669

2.38

57.00

12.9

nmol/l

818.9

842.4

0.46

388

1616

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

314

1155

2.67

56.58

2.1

2.2

umol/l

150.1

142.0

0.13

161

578

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1204

7266

1.64

55.49

2.1

2.4

g/l

0.5

0.8

3.63

1040

6312

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2889

20959

1.38

53.83

3.1

2.5

ml/min/173m2

65.0

69.9

6.28

1354

7889

(3012565) Volume of 24 hour Urine

324

1241

2.57

53.83

2.3

2.2

1932.2

2010.5

0.67

289

1125

(3025468) Yersinia sp identified in Specimen by Organism specific culture

646

3278

1.94

53.79

1.4

—

(3021788) Differential panel - Synovial fluid

821

4498

1.80

53.77

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

974

5606

1.72

53.73

1.6

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

646

3286

1.94

53.41

1.4

—

(3044941) Cell count panel - Synovial fluid

710

3736

1.87

52.96

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

661

3400

1.92

52.86

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

644

3284

1.93

52.85

1.4

—

(3019977) pH of Arterial blood

310

1179

2.58

52.27

2.7

2.5

7.4

1.36

124

391

(3024522) Salmonella sp identified in Specimen by Organism specific culture

647

3325

1.92

51.89

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

25906

240031

1.22

51.78

23.7

14.8

14.0

13.6

299.60

25568

235218

(3036489) Thrombin time

1605

10522

1.51

51.62

2.1

21.1

21.4

0.78

1357

9068

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1753

11712

1.49

51.42

1.3

u/ml

0.6

0.9

1.22

187

983

(3000034) Microalbumin [Mass/volume] in Urine

463

2119

2.15

51.18

3.7

2.8

mg/l

59.9

53.8

0.21

353

1481

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1082

6497

1.65

50.85

2.0

2.2

g/l

0.0

2.46

988

5963

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

22202

202872

1.19

50.84

3.6

3.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

642

3324

1.90

50.35

1.4

—

(36660697) Celiac disease serology panel - Serum

3194

23775

1.34

50.30

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1281

8037

1.58

50.24

1.4

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

289

1086

2.61

49.96

2.1

1.8

umol/l

27.1

29.4

3.09

281

1042

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1094

6630

1.63

49.56

1.9

2.2

g/l

36.7

38.2

13.67

945

5761

(40761536) Microorganisms panel - Urine sediment

3214

24021

1.34

49.19

4.8

3.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

576

2918

1.94

48.24

1.4

mmol/l

12.2

11.6

0.76

193

561

(3003129) Base excess in Capillary blood by calculation

178

521

3.35

48.12

1.7

mmol/l

0.6

0.01

170

486

(3023323) Follitropin [Units/volume] in Serum or Plasma

2491

17962

1.38

47.95

1.4

1.3

iu/l

20.4

27.8

36.01

2081

15575

(3011288) Drugs identified in Urine by Screen method

1405

9095

1.53

47.91

2.7

3.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

708

3846

1.82

47.72

2.9

3.2

1.3

1.5

0.89

551

2988

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1862

12768

1.45

47.72

2.5

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

814

4627

1.74

46.98

1.1

—

(3037756) Immunofixation for Serum or Plasma

789

4446

1.75

46.96

1.3

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

423

1947

2.14

46.13

1.1

1.3

u/ml

—

31.3

—

(3047181) Lactate [Moles/volume] in Blood

1201

7580

1.57

45.89

7.5

5.5

mmol/l

1.4

1.3

5.16

1087

6692

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

739

4119

1.77

45.69

1.6

1.7

—

(40768804) Tissue Pathology biopsy report

13057

114712

1.18

45.12

2.1

2.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3120

23521

1.33

44.76

1.4

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

720

4014

1.77

44.49

1.3

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

647

3496

1.82

44.40

2.7

2.6

u/ml

388.2

564.7

0.18

617

3285

(3020491) Glucose [Moles/volume] in Blood

427

2004

2.10

44.29

2.1

1.7

mmol/l

7.1

6.4

3.55

286

1525

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

987

5996

1.63

44.28

1.9

2.3

g/l

0.0

0.09

895

5478

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1377

9031

1.51

44.13

1.8

1.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

726

4067

1.76

44.12

4.5

3.3

66.8

64.6

1.89

721

4051

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1371

9015

1.51

43.39

2.3

93.7

92.6

0.96

1267

8363

(3044927) Protein electrophoresis panel - Urine

424

2009

2.08

42.89

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

763

4372

1.72

42.81

1.6

1.3

mmol/l

7.4

6.9

3.87

554

3151

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1272

8278

1.52

42.28

2.6

193.0

181.2

4.97

1201

7840

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

788

4573

1.70

42.21

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

177

563

3.08

41.80

1.2

pmol/l

321.6

339.7

0.17

121

427

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

965

5918

1.61

41.66

1.9

2.3

g/l

0.0

0.00

888

5465

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

461

2293

1.98

40.79

1.6

1.5

29.0

33.4

1.71

290

1420

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

571

3059

1.84

40.33

1.6

58.8

54.4

1.69

361

1939

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1713

11947

1.42

39.90

1.1

u/ml

2.6

11.6

1.61

182

(4034850)

1285

8497

1.50

39.55

10.7

8.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

643

3591

1.76

39.54

1.4

—

(3022621) pH of Urine by Test strip

2368

17450

1.35

39.47

3.4

2.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

517

2705

1.88

39.36

1.2

u/l

61.5

62.2

0.06

352

1811

(3014271) Vancomycin [Susceptibility]

243

945

2.52

39.27

3.3

2.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

730

4247

1.69

38.77

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

248

986

2.47

38.26

2.1

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1466

10025

1.45

38.01

1.2

1.3

—

(3006270) Folate [Moles/volume] in Blood

408

2004

2.00

37.46

1.2

1.1

nmol/l

385.4

378.7

0.26

324

1776

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

321

1454

2.17

36.59

1.3

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

583

3240

1.77

36.49

1.6

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

560

3078

1.79

36.39

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

316

1431

2.17

36.05

1.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1500

10418

1.43

35.72

2.2

—

(3001556) Androgen free Index in Serum or Plasma

115

309

3.65

35.57

1.3

1.1

—

(3022689) Creatine [Moles/volume] in Urine

189

691

2.68

34.69

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

435

2251

1.90

34.33

1.5

1.4

e6/l

102207.7

98163.4

0.05

319

1539

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

153

507

2.96

33.75

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1147

7668

1.48

33.43

2.5

2.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1220

8265

1.46

33.22

1.2

—

(4306422)

742

4526

1.62

32.81

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1208

8188

1.46

32.80

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

255

1101

2.27

32.74

1.3

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

1219

8281

1.45

32.71

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

255

1102

2.27

32.67

1.3

1.5

—

(3002256) Pathology report gross observation

4389

35765

1.23

32.58

1.2

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1283

8810

1.44

32.51

1.7

1.6

iu/ml

1.5

6.3

0.97

281

1753

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

423

2215

1.88

32.22

1.2

titre

178.6

172.7

0.05

378

(3051387) C reactive protein [Mass/volume] in Capillary blood

852

5424

1.55

31.37

4.7

3.1

mg/l

24.9

26.1

0.45

566

3321

(3004451) EKG impression Narrative

238

1017

2.30

31.34

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

419

2211

1.86

31.17

1.2

titre

172.3

163.1

0.03

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

224

935

2.35

31.14

2.5

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

470

2577

1.79

30.88

2.9

3.6

—

(3036603) Volume of Urine

343

1699

1.98

30.85

1.6

1951.5

1968.0

0.05

356

(40768443) Skin Pathology biopsy report

1611

11614

1.37

30.76

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

148

508

2.85

30.69

1.3

mu/l

93.5

81.1

0.21

105

391

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

394

2050

1.89

30.64

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

394

2050

1.89

30.64

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

394

2050

1.89

30.64

1.4

1.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

260

1164

2.19

30.62

1.5

1.4

mu/l

443.4

701.2

1.69

248

1107

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4788

39616

1.21

30.32

2.1

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

567

3300

1.69

30.16

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

729

4524

1.59

30.03

1.4

1.6

g/l

0.7

1.13

559

3436

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

728

4528

1.58

29.70

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

419

2252

1.83

29.43

1.5

2.2

—

(3045424) Erythrocytes [Presence] in Urine

742

4646

1.57

29.42

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

731

4574

1.57

29.07

1.3

1.2

u/ml

4.4

3.9

0.50

307

2037

(3034274) Bile acid [Moles/volume] in Serum --fasting

805

5148

1.54

29.06

2.3

2.1

umol/l

6.1

6.4

0.18

589

3748

(3008898) HLA-B27 [Presence]

1541

11133

1.37

29.03

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

261

1197

2.14

28.95

1.5

1.4

73.1

72.8

0.12

249

1140

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1387

9871

1.39

28.66

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

921

6080

1.49

28.62

1.5

1.4

u/ml

14.2

20.4

1.23

117

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

311

1533

1.99

28.41

1.4

1.5

u/ml

19.6

24.4

1.08

288

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

396

2116

1.84

28.36

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

748

4740

1.55

28.15

1.3

1.2

u/ml

3.8

3.5

0.15

232

1628

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

923

6117

1.49

28.14

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

700

4382

1.57

27.81

1.1

124.6

117.7

5.93

625

3965

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2477

30176

0.79

27.73

1.8

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

303

1494

1.99

27.68

1.3

1.2

u/l

82.8

87.9

0.48

267

1302

(3039000) Anion gap in Blood

812

5283

1.51

27.08

8.9

6.5

mmol/l

11.5

11.2

2.07

745

4751

(3018572) Chloride [Moles/volume] in Blood

812

5284

1.51

27.06

8.9

6.5

mmol/l

105.1

105.3

0.68

745

4752

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

658

4094

1.58

26.85

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

295

1457

1.99

26.84

1.3

1.2

u/l

20.7

22.6

0.41

252

1253

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

334

1722

1.90

26.78

2.5

2.1

98.8

0.00

308

1593

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

992

6737

1.45

26.70

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5225

44092

1.19

26.27

2.2

2.1

—

(4062490)

496

2896

1.68

26.14

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

495

2894

1.68

25.96

1.4

g/l

6.3

6.8

3.48

351

2041

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

400

2212

1.78

25.63

3.1

2.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

493

2891

1.68

25.58

1.4

g/l

2.8

3.0

1.30

353

2041

(3024139) IgG subclass 3 [Mass/volume] in Serum

493

2891

1.68

25.58

1.4

g/l

0.4

0.05

352

2046

(40757494) Bilirubin.total [Moles/volume] in Blood

259

1243

2.04

25.55

2.2

2.1

umol/l

17.7

32.0

1.51

112

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

171

693

2.42

25.51

2.3

1.8

e6/l

7294.9

10828.6

0.45

368

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

920

6218

1.46

25.41

1.2

1.3

mmol/l

4.0

3.7

13.98

849

5845

(3017315) Amylase [Enzymatic activity/volume] in Urine

286

1426

1.97

25.36

1.4

1.2

u/l

294.1

323.6

0.22

268

1328

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

333

1747

1.87

25.34

1.6

1.4

mmol/l

5.6

5.5

1.31

314

1659

(3004616) Nuclear Ab [Presence] in Serum

565

3438

1.62

25.34

1.3

—

(3016879) Cocaine [Presence] in Urine

1676

12519

1.32

25.27

2.2

2.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1933

14728

1.30

25.22

1.1

titre

177.8

203.4

0.14

376

(3000764) Benzodiazepines [Presence] in Urine

1790

13505

1.31

25.12

2.1

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

340

1801

1.85

25.11

1.6

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

848

5655

1.48

25.10

1.5

u/ml

106.5

112.8

1.19

215

1255

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1613

20496

0.76

25.04

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

405

2264

1.76

25.01

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

143

538

2.60

24.96

1.5

1.4

g/l

13.0

13.5

0.23

117

396

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

464

2696

1.69

24.93

1.7

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

186

792

2.30

24.82

2.3

1.9

e6/l

7357.0

1724.5

0.59

127

539

(3008116) Ketones [Moles/volume] in Urine by Test strip

136

502

2.65

24.66

1.4

—

(3045414) Leukocytes [Presence] in Urine

1657

12412

1.32

24.49

1.9

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

408

2302

1.74

24.41

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

212

962

2.16

24.26

1.3

1.4

pmol/l

13.3

14.7

3.13

176

815

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2067

15968

1.28

24.21

2.7

3.1

u/ml

38.6

49.0

1.77

1978

15447

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

899

6112

1.45

24.09

1.2

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

167

3.98

24.02

1.7

1.9

umol/l

45.2

0.00

167

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1079

7588

1.40

23.95

1.3

u/ml

4.8

9.4

3.57

150

1203

(3013727) Leukocytes other/100 leukocytes in Blood

175

738

2.32

23.91

3.0

3.3

55.8

52.5

1.27

169

719

(3027008) Opiates [Presence] in Urine

1789

13599

1.30

23.74

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

1792

13633

1.30

23.63

2.1

—

(3033799) Differential panel - Peritoneal fluid

166

689

2.36

23.52

2.3

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

892

6083

1.44

23.52

1.2

1.3

u/ml

4.5

5.5

0.19

464

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1157

8261

1.38

23.46

1.3

u/ml

28.0

37.5

0.46

518

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

523

3187

1.61

23.36

1.8

1.6

mmol/l

8.5

7.4

14.82

317

1902

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

879

5992

1.44

23.23

1.2

u/ml

12.5

15.1

0.11

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

849

5751

1.45

23.21

1.3

u/ml

276.6

263.9

0.67

525

3765

(3004716) Salmonella sp identified in Stool by Organism specific culture

2069

16085

1.27

23.01

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

126

464

2.66

22.99

1.5

1.4

g/l

25.9

29.0

0.43

355

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2071

16105

1.27

22.98

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

127

472

2.64

22.76

1.9

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1114

7948

1.38

22.70

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1010

7096

1.40

22.56

1.3

1.4

mg/l

529.4

512.3

0.22

950

6774

(44806118)

468

2808

1.64

22.28

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

113

400

2.77

22.28

3.0

2.3

—

(3023419) Bacteria identified in Sputum by Culture

481

2906

1.63

22.27

2.6

2.5

—

(44790048)

468

2809

1.64

22.25

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1053

7472

1.39

22.18

1.3

u/ml

6.4

0.01

103

785

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1043

7391

1.39

22.15

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

598

3808

1.54

22.12

1.4

mmol/l

62.8

64.3

0.33

446

3013

(3020191) Ethanol [Moles/volume] in Serum or Plasma

393

2257

1.71

22.12

1.7

1.5

promille

1.2

1.4

1.45

299

1723

(44790049)

467

2808

1.63

22.05

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

445

2644

1.65

22.03

1.5

1.7

—

(44790047)

467

2809

1.63

22.02

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

27985

265863

1.15

21.89

20.8

13.1

39.7

40.0

4.43

19881

204177

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

412

2407

1.68

21.76

1.5

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1850

14307

1.28

21.46

1.6

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

194

894

2.13

21.42

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

1140

8252

1.36

21.24

2.2

2.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

268

1393

1.89

21.09

1.1

u/ml

8.9

10.1

0.17

255

(3045716) Anion gap in Serum or Plasma

211

1012

2.04

20.96

2.5

mmol/l

9.3

9.2

0.09

166

730

(3027944) Amphetamines [Presence] in Urine

1737

13390

1.28

20.67

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4557

38744

1.17

20.46

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

245

3.20

20.40

8.3

7.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

404

2391

1.66

20.35

2.9

3.3

60.3

58.0

1.25

259

1549

(3013166) Neutrophils/100 leukocytes in Synovial fluid

162

715

2.22

19.97

1.6

1.4

53.3

52.4

0.11

141

612

(43055442) Apixaban [Mass/volume] in Serum or Plasma

236

3.19

19.62

1.5

ug/l

114.0

111.9

0.05

199

(3010838) Calcium [Moles/time] in 24 hour Urine

241

1240

1.91

19.61

1.7

1.6

mmol/24h

6.2

5.4

0.26

112

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

340

2.79

19.54

14.5

9.7

mmol/l

5.5

5.3

0.23

340

(3044290) Cell count panel - Cerebral spinal fluid

840

5866

1.41

19.48

1.3

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

245

1273

1.89

19.36

1.2

1.1

iu/ml

3.3

3.6

0.29

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

803

5573

1.42

19.30

5.5

6.0

iu/ml

6646.9

1287.1

0.43

105

829

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

205

1004

2.00

19.27

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

505

3198

1.55

19.22

1.2

1.1

97.1

94.8

1.11

473

2996

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

189

902

2.05

19.09

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1402

10630

1.30

18.97

1.5

—

(3042631) Mycobacterium sp identified in Specimen

484

3049

1.56

18.87

2.4

2.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1032

7500

1.36

18.78

1.9

iu/l

3.8

20.4

1.40

378

2861

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

252

1336

1.85

18.72

1.2

1.3

titre

62.2

76.3

0.33

114

(3003327) Ova and parasites identified in Stool by Light microscopy

1368

10359

1.30

18.69

1.8

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

257

1372

1.84

18.67

1.2

1.3

titre

601.1

413.1

0.28

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

200

983

1.99

18.64

2.0

2.5

ug/l

0.8

1.2

2.61

181

941

(40762365) Oxygen content in Arterial blood by calculation

360

2.69

18.62

2.6

3.0

ml/dl

14.9

0.04

336

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

674

2.21

18.56

3.4

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

674

2.21

18.56

3.4

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

339

2.74

18.53

5.9

5.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

358

2107

1.67

18.48

1.4

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

174

817

2.09

18.38

6.9

6.1

mmol/l

25.7

24.9

1.17

157

748

(3006922) Hepatitis E virus Ab [Presence] in Serum

343

2000

1.68

18.35

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

6.02

18.30

4.9

5.6

mmol/l

0.2

0.14

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

508

3266

1.53

18.09

1.2

1.1

iu/ml

1.0

2.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

113

446

2.48

18.01

3.5

2.2

mmol/l

7.8

7.4

0.37

265

(3038026) Centromere Ab [Units/volume] in Serum

369

2209

1.64

17.84

1.2

u/ml

48.4

47.5

—

103

(3037556) Urate [Mass/volume] in Serum or Plasma

146

648

2.21

17.81

1.4

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

164

763

2.11

17.76

1.2

—

(44806420)

125

522

2.34

17.62

2.2

2.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

228

1197

1.87

17.50

1.5

5.1

3.8

0.59

277

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

628

4244

1.45

17.50

2.6

3.0

u/ml

513.5

7461.8

1.40

238

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

330

1930

1.68

17.48

1.1

ratio

1.1

0.48

107

709

(3019420) Tryptase [Mass/volume] in Serum or Plasma

286

1609

1.74

17.46

1.3

1.5

ug/l

6.5

8.1

1.75

257

1452

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

212

1090

1.91

17.36

3.1

3.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

287

1619

1.74

17.36

1.6

u/l

6.3

6.6

0.07

142

780

(3022493) Free Hemoglobin [Mass/volume] in Plasma

206

1055

1.91

17.08

6.1

5.0

mg/l

1895.3

3128.1

0.39

147

783

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

296

1694

1.71

17.01

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

159

3.51

16.90

2.0

1.3

umol/24h

351.0

316.6

0.56

159

(3035320) C reactive protein [Mass/volume] in Body fluid

332

1964

1.66

16.86

3.1

2.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

277

4552

0.59

16.82

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1402

10798

1.28

16.82

1.9

1.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

356

2157

1.62

16.45

1.2

u/ml

78.9

65.8

0.30

105

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

296

1715

1.69

16.28

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

356

2163

1.61

16.27

1.2

u/ml

52.7

43.7

0.27

165

(3026389) Candida sp identified in Specimen by Organism specific culture

626

4290

1.43

16.22

1.4

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

866

6288

1.35

15.91

1.4

1.5

e6/l

1148.1

2383.6

0.90

696

5100

(3051611) Lipemic interference index of Serum or Plasma

409

2586

1.55

15.78

3.7

3.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

864

6282

1.35

15.74

1.3

1.4

e6/l

62.9

22.7

1.07

658

4849

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

115

489

2.30

15.61

1.3

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

974

7221

1.33

15.56

1.4

pmol/l

130.2

117.7

0.42

939

7051

(3051651) Icteric interference index of Serum or Plasma

263

1496

1.72

15.50

3.9

3.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

340

2074

1.61

15.32

1.2

u/ml

6.0

10.9

0.73

159

(3044007) Cell count panel - Peritoneal fluid

138

638

2.12

15.28

2.5

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1146

8713

1.29

15.24

1.1

u/ml

4.0

5.5

1.17

134

1249

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

290

1704

1.67

15.17

1.5

1.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

230

1268

1.78

15.14

2.0

2.3

ug/l

21.8

172.1

1.83

218

1208

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

308

1840

1.64

15.11

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.87

15.07

1.1

nmol/24h

86.1

105.4

0.71

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

309

1849

1.64

15.06

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

272

1578

1.69

14.94

1.1

nmol/l

2.2

6.1

1.66

301

(3051593) INR in Capillary blood by Coagulation assay

182

938

1.90

14.88

13.2

8.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

332

2032

1.60

14.78

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

143

680

2.06

14.72

1.6

1.2

nmol/l

83.4

132.6

4.45

102

513

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

239

1344

1.74

14.71

1.1

u/l

19.3

24.6

1.09

186

1044

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

226

1252

1.77

14.65

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

226

1252

1.77

14.65

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

226

1252

1.77

14.65

1.5

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

249

1419

1.72

14.62

1.6

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

238

1346

1.73

14.37

1.1

u/l

79.6

84.7

0.61

194

1079

(3024263) Appearance of Synovial fluid

225

1253

1.76

14.34

2.0

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

196

1049

1.83

14.27

3.1

2.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

225

1255

1.76

14.26

1.5

2.0

—

(3042733) HLA Ab [Presence] in Serum

184

966

1.87

14.24

5.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1134

8692

1.28

14.19

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2414

20045

1.19

14.17

2.4

2.3

au/ml

23.9

23.1

0.11

1331

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

324

1997

1.59

14.03

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

362

2289

1.55

14.03

1.9

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

322

1982

1.59

14.03

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

373

2377

1.54

13.96

1.5

mosm/kgh2o

283.2

280.1

1.67

284

1859

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

391

2519

1.52

13.92

1.3

1.6

—

(44813793)

349

2198

1.56

13.78

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2597

21768

1.18

13.65

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

404

2634

1.50

13.61

1.5

1.4

g/l

33.3

33.7

0.29

373

2388

(4024509)

367

2349

1.53

13.49

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

695

5009

1.36

13.47

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2220

18387

1.19

13.41

1.3

au/ml

41.7

47.1

0.37

768

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

312

1931

1.58

13.31

2.2

1.9

u/field

2.4

2.1

0.42

143

894

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

111

501

2.17

13.14

3.0

2.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

746

9642

0.75

13.11

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

184

997

1.81

12.92

3.5

4.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

186

1012

1.80

12.89

1.2

110.7

111.3

0.13

161

912

(4198724)

244

1436

1.66

12.78

2.2

2.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

197

1095

1.76

12.70

1.2

g/l

0.3

2.49

156

864

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

237

1388

1.67

12.66

1.1

99.7

95.9

1.07

178

1111

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

245

1448

1.66

12.63

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

771

9855

0.76

12.52

1.6

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

267

1617

1.62

12.50

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

100

442

2.21

12.49

2.2

2.7

mg/l

95.1

32.3

1.25

(3005033) Fetal Nuchal fold Thickness US

751

9619

0.76

12.39

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

247

1474

1.64

12.28

1.6

1.9

153.9

135.6

2.90

231

1391

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

174

942

1.81

12.28

2.6

2.2

—

(4268621)

461

3157

1.43

12.13

2.4

2.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

223

2.72

12.08

1.4

1.3

mg/24h

857.9

229.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

118

567

2.04

11.91

1.4

1.6

ug/l

0.4

0.31

382

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

218

1270

1.68

11.91

1.6

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

835

6305

1.30

11.80

1.2

u/ml

33.0

43.1

1.02

623

(3000012) Reticulocyte production index

211

1222

1.69

11.79

1.3

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

334

2161

1.52

11.75

1.2

1.3

u/ml

0.7

1.1

0.68

153

915

(40768446) Kidney Pathology biopsy report

192

1091

1.72

11.51

1.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

11544

106614

1.09

11.47

3.4

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

361

2386

1.48

11.46

1.5

e6/l

5545.9

3192.2

0.41

269

1721

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

184

1035

1.74

11.44

1.1

94.0

91.7

0.46

464

(3010375) cycloSPORINE [Mass/volume] in Blood

209

1224

1.67

11.23

28.5

28.4

ug/l

118.2

118.4

0.01

167

1027

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

393

2.22

11.19

4.0

5.3

ug/min

66.2

40.7

1.84

298

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

221

2.66

11.19

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

238

2.59

11.18

2.0

2.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

275

1725

1.56

11.17

2.8

3.3

nmol/l

117.4

128.2

0.23

269

1693

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

394

2.21

11.13

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

463

3234

1.40

10.96

1.5

1.6

iu/ml

29.9

33.7

0.27

160

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

264

2.48

10.91

1.1

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

443

3076

1.41

10.85

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

216

1288

1.64

10.84

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1024

8022

1.25

10.79

1.2

—

(3016038) Potassium [Moles/volume] in Urine

239

1465

1.60

10.73

1.2

1.3

mmol/l

31.3

34.5

1.45

199

1269

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

330

2175

1.49

10.67

1.1

1.3

mmol/l

2.1

2.0

0.85

299

2031

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

188

2.76

10.65

2.4

2.2

66.9

57.4

1.03

113

(3014148) Varicella zoster virus Ab [Titer] in Serum

589

4298

1.34

10.64

1.2

—

(3024932) HLA-DR beta [Type]

169

949

1.74

10.61

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

242

1498

1.58

10.44

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

380

2.19

10.41

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

231

1416

1.60

10.39

1.3

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

249

1554

1.57

10.38

1.5

1.4

u/l

13.3

12.2

1.42

244

1506

(3024471) HLA-A [Type]

171

976

1.72

10.16

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

182

1058

1.68

10.11

1.2

114.9

110.2

0.87

165

957

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

242

1513

1.57

10.03

1.2

u/ml

35.4

10.6

0.33

166

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

171

980

1.71

10.02

1.5

2.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

278

1793

1.52

10.01

1.3

u/l

595.7

496.2

0.24

265

1705

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

419

2.10

9.97

5.8

5.6

64.3

70.0

1.18

326

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

173

997

1.70

9.94

1.5

2.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

147

2.93

9.88

2.3

13.4

17.1

0.43

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

603

4470

1.32

9.82

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

175

1015

1.69

9.82

1.1

96.9

93.3

0.59

461

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

170

980

1.70

9.76

1.5

2.2

—

(40768800) Prostate Pathology biopsy report

297

4243

0.68

9.76

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1392

11397

1.20

9.61

1.4

1.3

miu/ml

196.8

226.9

2.46

566

5535

(3026250) Tacrolimus [Mass/volume] in Blood

208

1271

1.60

9.53

36.5

36.1

ug/l

7.3

7.4

0.28

187

1157

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

325

2187

1.46

9.52

3.4

3.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

303

2012

1.48

9.50

1.3

1.4

umol/l

12.7

11.6

1.99

271

1923

(4015189)

116

603

1.88

9.44

2.5

2.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

141

2.91

9.37

2.0

1.7

0.6

0.7

0.14

107

(3028308) Erythrocytes [#/volume] in Pleural fluid

322

2171

1.45

9.34

1.5

e6/l

81177.0

48918.4

0.99

188

1295

(3043410) Blood group antigens tested for on Red Blood Cells

129

698

1.81

9.26

1.7

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

772

5977

1.27

9.06

1.1

u/ml

4.3

5.4

1.43

414

3041

(3001729) Color of Synovial fluid

171

2.69

9.06

1.9

1.6

—

(3025315) Body weight

211

2.50

9.03

5.1

4.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

104

532

1.91

8.92

1.2

mg/l

17.3

58.6

0.97

392

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

127

693

1.79

8.89

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

181

1090

1.63

8.84

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

249

2.36

8.82

1.0

1.2

mg/l

39.0

46.1

1.76

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

137

768

1.75

8.75

1.6

ug/l

10.8

8.8

4.31

137

768

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

299

2.22

8.75

3.0

2.5

mmol/l

1.4

1.2

0.15

211

(3023383) Lactate [Moles/volume] in Pleural fluid

110

578

1.86

8.70

1.3

mmol/l

3.6

3.5

0.09

102

531

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

383

2.07

8.68

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

734

5681

1.27

8.66

1.1

u/ml

1.1

0.04

324

2383

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

847

6667

1.25

8.65

1.1

u/ml

1.3

1.7

0.77

385

2635

(3017704) Immunofixation for Urine

193

1190

1.59

8.57

1.3

1.7

—

(3035880) pH of Pleural fluid

176

1062

1.62

8.55

1.2

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

509

3763

1.33

8.52

1.3

1.2

u/ml

35.1

52.8

0.91

259

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1031

12169

0.82

8.51

1.5

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

250

1636

1.50

8.49

1.6

1.4

u/l

6.1

5.9

0.12

220

1368

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

289

1956

1.45

8.28

1.1

iu/ml

7.0

8.4

0.83

510

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1055

8551

1.21

8.16

3.0

3.5

u/ml

1169.9

2105.9

0.45

882

7344

(3012494) Peanut IgE Ab [Units/volume] in Serum

155

920

1.65

8.07

1.1

u/ml

2.6

6.5

0.51

524

(4094501)

883

7039

1.23

8.05

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

272

2.23

8.05

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

292

2.18

7.97

2.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

400

2885

1.36

7.94

3.1

3.3

nmol/l

5.9

7.8

0.41

371

2796

(4211845)

222

1439

1.51

7.93

3.3

2.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

587

4473

1.29

7.90

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

102

541

1.84

7.88

1.1

umol/24h

0.9

0.8

0.23

275

(3047189) Immunofixation for 24 hour Urine

165

1003

1.61

7.82

1.4

1.9

—

(3018133) Calcium [Moles/volume] in Urine

434

1.94

7.74

2.2

2.0

mmol/l

3.2

2.5

1.42

393

(3023410) Appearance of Cerebral spinal fluid

400

2899

1.35

7.71

1.4

1.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

462

1.91

7.70

1.4

25.3

24.1

0.13

387

(3036670) Protein [Mass/volume] in Synovial fluid

122

688

1.74

7.70

1.4

1.2

g/l

37.4

40.1

1.20

364

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2826

24807

1.12

7.67

3.4

4.1

ug/l

23.3

23.9

0.04

2247

19514

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

378

1.99

7.51

1.3

1.5

nmol/l

458069.9

197484.0

0.45

317

(3028433) Virus identified in Specimen by Culture

149

895

1.63

7.44

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

389

2827

1.35

7.39

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1428

11998

1.17

7.38

1.4

1.5

—

(4281824)

405

2963

1.34

7.36

1.2

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.39

7.23

1.2

1.3

—

(3006462) Nitrate [Presence] in Urine

202

1312

1.51

7.19

3.5

2.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

312

2210

1.38

7.00

1.8

2.1

74.4

73.2

0.73

305

2120

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3782

33912

1.10

6.88

1.5

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

150

2.54

6.82

1.2

ug/l

146.7

105.8

0.94

(3012441) Differential panel - Pleural fluid

293

2064

1.39

6.81

1.5

—

(3011412) CD3 cells [#/volume] in Blood

379

2783

1.33

6.76

2.1

2.5

e9/l

1.3

1.2

0.84

225

1654

(40768793) Breast Pathology biopsy report

547

6721

0.79

6.69

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

213

1421

1.47

6.69

1.7

u/field

2.5

2.4

0.08

153

1025

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

278

1950

1.40

6.64

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

255

1764

1.42

6.60

1.9

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

357

4622

0.75

6.59

3.2

3.6

u/ml

25.2

37.3

1.77

339

4449

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

305

2177

1.37

6.56

1.8

2.1

13.1

13.8

0.50

155

1060

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

439

1.85

6.55

1.2

1.1

u/ml

0.3

0.01

266

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

721

5763

1.23

6.50

1.5

1.4

nmol/l

0.4

0.78

575

4547

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

208

2.26

6.50

1.4

1.3

ml/s/173m2

1.0

1.7

0.89

139

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

211

1414

1.46

6.49

1.3

u/l

14.8

14.5

0.06

194

1307

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

154

2.48

6.48

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

3.79

6.45

1.0

1.1

mu/l

81.1

69.0

0.10

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.31

6.41

1.3

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

108

622

1.70

6.40

1.3

35.5

40.7

0.66

423

(3013466) aPTT in Blood by Coagulation assay

185

2.33

6.39

1.2

1.1

38.9

36.2

0.86

152

(3045788) Cell count panel - Pleural fluid

264

1849

1.40

6.38

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

329

2389

1.35

6.36

1.2

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

151

949

1.56

6.32

1.2

g/l

0.1

0.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

276

1952

1.38

6.30

1.3

mmol/l

6.8

6.2

2.27

255

1801

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

134

2.55

6.21

1.0

u/ml

0.3

0.1

0.70

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

174

1133

1.50

6.20

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

286

2043

1.37

6.15

2.2

2.6

e6/l

539.9

512.0

0.50

244

1701

(40762814) Titanium [Mass/volume] in Blood

358

1.91

6.15

2.2

2.3

ug/l

3.7

4.0

0.15

128

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

220

2.18

6.12

1.2

1.4

66.2

69.3

0.25

183

(3041806) Other cells [#/volume] in Blood by Manual count

1499

0.59

6.11

1.6

1.5

—

(44806071)

394

1.86

6.08

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

487

3757

1.27

6.06

2.4

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

558

4375

1.25

6.05

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

108

633

1.67

6.03

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

382

1.87

6.00

2.8

2.9

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

203

2.22

5.99

1.4

pmol/l

7.3

14.5

1.52

168

(3047007) Chlamydophila sp Ab [Presence] in Serum

574

4523

1.24

5.96

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

391

2943

1.30

5.91

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

277

1986

1.37

5.85

2.2

2.6

e9/l

0.2

0.23

243

1706

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

156

1008

1.51

5.79

1.1

1.0

u/ml

9.0

10.3

0.17

134

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

104

612

1.66

5.74

7.7

8.9

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

207

2.17

5.73

1.4

1.2

mmol/l

23.2

21.1

1.69

162

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

346

2574

1.32

5.72

1.1

1.2

mg/l

42.1

41.8

0.04

294

2147

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

100

2.74

5.71

1.1

1.4

nmol/l

552.1

490.4

0.22

100

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

326

2407

1.33

5.69

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

109

651

1.64

5.68

1.5

2.0

u/l

33.4

34.2

0.02

584

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

334

1.90

5.67

2.3

2.7

pmol/l

82.5

59.1

0.62

284

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

336

2493

1.32

5.66

1.1

mg/l

227.4

258.0

2.30

291

2191

(3002619) Bacteria identified in Specimen by Culture

541

1.70

5.64

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

268

1925

1.36

5.62

1.7

1.4

umol/l

64.6

69.9

1.25

166

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

166

1097

1.48

5.55

1.7

1.9

177.7

155.9

1.68

156

1037

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.20

5.35

1.0

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.86

5.32

1.0

1.1

pmol/l

174.0

230.7

0.45

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

342

1.86

5.30

1.7

3.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

600

4820

1.22

5.25

2.7

3.5

u/ml

664.1

841.2

0.25

539

4380

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

523

1.68

5.25

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

575

1.65

5.25

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.15

5.22

10.3

7.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

511

1.68

5.15

1.3

1.5

nmol/l

0.2

0.3

0.90

369

(3019897) Erythrocyte distribution width [Ratio] by Automated count

395

4876

0.79

5.14

3.4

2.4

13.5

13.1

8.56

389

4818

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2971

26709

1.10

5.13

2.0

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

746

6133

1.19

5.13

2.1

2.0

—

(40768806) Pleura Pathology biopsy report

282

2074

1.33

5.11

1.6

1.5

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

522

1.67

5.03

1.3

25.2

22.3

0.40

478

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

143

2.32

5.01

1.1

1.3

—

303.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

539

4306

1.23

5.00

1.8

2.0

titre

7.8

7.7

0.00

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

446

3492

1.25

4.98

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

159

1067

1.46

4.97

2.3

2.7

au/ml

158.1

148.6

0.10

155

(3001686) Cold agglutinin [Titer] in Serum or Plasma

443

1.72

4.97

1.2

1.4

titre

25.0

170.9

—

(3026470) Cobalt [Mass/volume] in Blood

188

1306

1.41

4.88

2.0

ug/l

5.2

3.2

1.17

158

1163

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.93

4.87

1.1

mmol/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

279

2066

1.32

4.84

1.8

2.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

411

1.74

4.81

1.8

1.7

pmol/l

45.7

43.3

0.10

346

(40757373) Influenza virus identified in Isolate

470

1.69

4.79

1.8

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

151

1012

1.46

4.77

2.6

2.4

nmol/l

145.2

152.9

0.45

134

886

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.63

4.76

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5359

55393

0.94

4.76

3.9

4.0

22.5

21.7

2.19

2149

25882

(4027681)

272

2014

1.32

4.74

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

702

5788

1.19

4.71

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

218

2.02

4.71

1.2

nmol/l

18.0

15.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.67

4.70

1.9

2.1

—

(3011436) Histone Ab [Units/volume] in Serum

581

1.60

4.59

1.1

u/ml

—

36.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2348

20993

1.10

4.58

1.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.20

4.55

1.9

2.3

mu/l

2.4

2.3

0.04

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

165

1137

1.42

4.52

2.5

2.4

umol/l

55.6

52.9

0.46

129

955

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

169

1171

1.41

4.49

2.8

3.2

mg/l

7.8

8.1

0.22

131

933

(3025577) Chromium [Mass/volume] in Blood

182

1278

1.39

4.48

2.0

2.1

ug/l

2.7

2.2

0.44

148

1074

(3052592) Norovirus Ag [Presence] in Stool

457

1.67

4.48

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

469

3741

1.23

4.47

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

236

1.95

4.47

1.2

1.3

27.6

25.2

0.17

182

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

135

899

1.47

4.44

1.3

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

142

955

1.45

4.44

2.4

3.0

umol/l

29.5

28.5

0.45

742

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

564

1.60

4.42

1.3

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

378

1.73

4.41

1.2

mmol/l

1.5

1.8

0.81

224

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

361

2803

1.26

4.39

3.8

4.7

u/ml

108.9

107.1

0.02

108

886

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

121

2.34

4.39

1.0

u/ml

0.1

0.35

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

107

681

1.54

4.38

1.2

122.1

106.6

3.93

102

640

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

109

697

1.53

4.37

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

355

2754

1.26

4.36

1.7

2.0

ug/l

25.1

24.3

0.07

344

2693

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7402

69169

1.06

4.36

4.4

4.7

ug/l

2.2

2.9

2.04

6516

62664

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

153

2.17

4.32

1.2

1.8

ug/g

200.4

177.7

0.34

132

(3051339) Copper [Moles/volume] in Blood

147

2.19

4.30

1.4

1.3

umol/l

17.2

16.6

0.25

128

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

353

1.75

4.26

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

103

655

1.54

4.24

1.2

73.9

74.9

0.06

159

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

108

694

1.52

4.24

1.3

1.4

60.1

61.5

0.16

576

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.86

4.24

1.9

1.6

nmol/l

149.2

338.2

1.47

(3048879) Bone marrow aspiration report

100

632

1.55

4.24

1.3

2.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

103

656

1.54

4.22

1.2

91.2

86.6

0.40

166

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

181

2.05

4.20

1.0

1.2

37.0

19.5

—

(3036180) Methadone [Presence] in Urine

3.02

4.17

1.9

2.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

158

1098

1.41

4.17

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

102

651

1.53

4.14

1.0

1.1

u/ml

2.8

1.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

182

2.04

4.14

1.1

u/ml

1.4

1.1

0.12

127

(3001218) Citrate [Mass/time] in 24 hour Urine

3.78

4.10

1.3

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

584

1.56

4.07

1.2

1.4

2.5

2.7

0.09

495

(3011335) Digoxin [Mass/volume] in Serum or Plasma

145

2.16

4.02

2.5

2.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

703

1.50

4.02

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3875

40264

0.93

4.00

2.8

2.9

ug/l

0.7

3.30

2560

25702

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

154

1075

1.40

3.98

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

545

1.56

3.87

8.0

8.9

—

(3016228) CD19 cells/100 cells in Blood

155

1090

1.39

3.85

1.7

2.1

8.8

8.5

0.15

150

1064

(3020393) Adenovirus Ag [Presence] in Stool

285

1.78

3.83

1.2

1.3

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.86

3.83

11.6

7.2

48.6

45.5

0.15

(3038177) Helicobacter pylori Ab [Presence] in Serum

614

5107

1.18

3.80

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

675

5663

1.17

3.76

1.1

u/ml

2.3

0.03

169

1388

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

652

1.50

3.72

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

194

1424

1.33

3.69

1.3

59.8

65.9

0.36

169

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1071

11759

0.89

3.68

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

608

1.51

3.64

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1071

11752

0.89

3.64

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

153

1085

1.38

3.64

1.9

2.0

mg/l

7.1

9.5

7.22

124

872

(3010503) CD19 cells [#/volume] in Blood

223

1674

1.30

3.63

2.3

2.6

e9/l

0.2

0.3

0.65

214

1634

(3045683) HLA typing for celiac disease panel - Blood or Tissue

255

1949

1.28

3.62

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1070

11730

0.89

3.59

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1067

11694

0.89

3.57

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

358

1.67

3.56

1.3

57.6

53.8

0.23

173

(3029612) Listeria sp Ab [Titer] in Serum

2.58

3.55

1.2

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

351

1.67

3.55

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

232

1759

1.29

3.52

1.1

u/l

1.2

1.1

0.39

100

781

(21494814) CD8 cells/100 lymphocytes in Specimen

150

1068

1.37

3.50

1.7

2.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

368

1.65

3.48

9.4

7.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

172

1254

1.34

3.46

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

252

1.78

3.43

1.0

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

163

1182

1.35

3.40

2.0

2.3

10.6

10.1

0.19

157

1095

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

350

2797

1.22

3.39

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

191

1.89

3.33

1.1

1.0

u/ml

0.1

0.6

1.86

174

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

465

1.56

3.31

2.7

4.9

u/l

57.2

58.3

0.03

174

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

105

710

1.45

3.31

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

575

4821

1.17

3.29

1.1

au/ml

15.5

10.5

0.44

331

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

521

1.52

3.27

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

164

1199

1.34

3.26

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

293

1.70

3.25

1.2

mmol/l

0.7

1.3

0.92

186

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

125

877

1.39

3.22

1.8

1.7

au/ml

182.0

129.2

0.55

104

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

113

2.16

3.22

1.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.44

3.21

1.7

1.5

nmol/l

276.7

252.4

0.06

(3027874) Urate [Moles/volume] in Urine

2.44

3.21

1.1

mmol/l

1.2

1.8

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.85

3.15

1.1

1.0

g/l

0.0

0.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

440

1.56

3.14

1.2

1.4

ng/l

53.8

310.6

0.70

269

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

1326

1.31

3.13

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

130

924

1.38

3.11

2.0

1.7

u/ml

3866.8

32277.6

1.15

114

(3042301) Urate [Moles/volume] in Synovial fluid

2.95

3.11

1.0

umol/l

502.3

368.1

—

(3034426) Prothrombin time (PT)

145

1049

1.35

3.11

1.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

460

5289

0.85

3.10

1.6

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

102

697

1.43

3.07

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

156

1144

1.33

3.06

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

156

1144

1.33

3.06

1.5

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

336

1.63

3.06

1.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

103

707

1.42

3.03

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

168

2140

0.77

3.01

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

532

1.49

2.99

1.3

1.2

ug/l

288.1

325.2

0.05

290

(3011325) HIV 1+2 Ab [Presence] in Serum

144

1.97

2.95

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

272

1.69

2.95

1.6

mg/l

0.6

2.0

3.77

175

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

151

1.94

2.94

1.1

u/l

35.6

61.7

1.64

119

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.16

2.93

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

535

1.48

2.92

1.4

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

296

1.65

2.89

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

2.82

2.89

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

104

722

1.41

2.89

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.17

2.89

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5638

57385

0.95

2.87

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1160

12483

0.90

2.85

1.5

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.57

2.82

1.3

1.0

u/field

1.1

1.2

0.27

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

398

1.55

2.81

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

175

1.84

2.79

1.2

1.1

u/l

9.1

9.8

0.09

175

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

193

1479

1.28

2.78

1.1

miu/ml

1510.5

1503.1

0.03

193

1479

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

308

1.62

2.75

3.8

3.4

umol/l

38.1

42.6

0.78

266

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

102

714

1.40

2.73

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

138

1016

1.33

2.69

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

250

1.68

2.68

1.3

u/l

77.5

337.5

0.78

183

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

243

1.69

2.67

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

296

1.62

2.65

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

776

6758

1.12

2.64

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

121

877

1.35

2.63

2.8

3.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

116

1521

0.74

2.61

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

170

1295

1.28

2.60

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

295

2390

1.21

2.59

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.53

2.57

1.1

g/l

0.0

0.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

209

1.73

2.57

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

202

1574

1.26

2.57

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

295

2393

1.21

2.56

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

239

1.68

2.55

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

225

1777

1.24

2.54

2.4

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

180

1386

1.27

2.53

1.2

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

294

2388

1.20

2.53

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

122

892

1.34

2.52

1.6

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

297

2417

1.20

2.51

1.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

6.98

2.51

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

296

2412

1.20

2.47

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.10

2.46

1.1

u/field

0.9

1.4

0.80

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

113

1.99

2.45

1.6

u/l

0.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

296

2414

1.20

2.45

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.25

2.44

1.0

1.1

ng/l

1543.6

4040.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

379

3162

1.17

2.42

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

335

1.55

2.41

1.7

mg/l

2.0

1.6

1.04

277

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

359

1.52

2.39

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

105

1376

0.74

2.39

1.0

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

149

1.84

2.38

1.0

1.2

u/field

1.1

1.2

0.36

(3029075) Extractable nuclear Ab panel - Serum

124

918

1.32

2.37

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

1.0

2.4

2.53

172

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

0.3

1.0

2.54

177

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

1.9

2.6

0.31

183

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

0.8

1.2

0.63

166

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

2.1

2.6

0.31

182

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

0.7

2.1

3.12

157

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

1.9

1.7

0.15

188

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

2.2

2.1

0.03

195

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

267

1.61

2.37

1.6

mg/l

3.1

4.0

0.41

167

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

431

3641

1.16

2.36

1.6

1.7

titre

5280.0

2675.8

—

125

(21494434) Karyotype in Bone marrow

245

1972

1.22

2.34

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

703

1.36

2.32

1.2

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

174

1352

1.26

2.31

1.5

1.6

iu/ml

2306390.8

1779560.4

0.17

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

355

1.51

2.29

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

443

1.46

2.28

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

166

1.77

2.27

1.3

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

286

1.57

2.26

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

850

1.32

2.25

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

117

868

1.32

2.23

1.5

—

(40758358) Immune stain study

118

1.91

2.20

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

118

1.91

2.20

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

3.80

2.20

1.0

1.1

—

(4212803)

190

1.70

2.19

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

530

4570

1.14

2.19

1.1

u/ml

6.0

4.9

0.35

224

1865

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

368

1.49

2.16

1.4

1.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.03

2.16

1.3

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

530

1.40

2.15

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

221

1.64

2.15

1.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

252

2058

1.20

2.11

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

134

1.82

2.11

3.6

3.2

—

(3019174) dRVVT (LA screen)

276

1.56

2.10

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

451

1.43

2.10

1.6

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

543

4718

1.13

2.01

1.1

u/ml

3.4

2.9

0.34

234

2382

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.00

1.98

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

118

894

1.29

1.97

1.9

2.2

e6/l

256.3

588.6

0.61

489

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

143

1112

1.26

1.94

1.1

ng/l

234.8

639.0

1.18

258

(3050794) Legionella sp Ab [Presence] in Serum

220

1.60

1.94

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1080

11425

0.92

1.94

2.1

1.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

117

889

1.29

1.92

1.3

1.2

27.6

20.1

0.41

153

(3009015) Lactate [Moles/volume] in Synovial fluid

244

1.56

1.91

1.4

1.2

mmol/l

5.8

6.1

0.10

118

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.06

1.91

1.0

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

222

1.59

1.88

1.1

—

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

277

1.52

1.86

1.1

—

(3007733) Chloride [Moles/volume] in Urine

2.14

1.84

1.2

1.6

mmol/l

78.2

89.6

0.41

(3005011) Chlamydia sp Ab [Titer] in Serum

415

1.41

1.83

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

717

1.31

1.81

1.0

1.1

mg/g

6.0

6.5

0.54

678

(3003157) Bacteria [#/volume] in Mother's milk

2.06

1.81

5.5

6.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

454

3937

1.13

1.78

1.1

1.0

u/ml

0.8

0.4

0.46

123

806

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

173

1.64

1.74

3.0

5.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

412

1.40

1.72

6.3

7.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

259

1.51

1.72

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

553

4866

1.11

1.70

1.1

u/ml

5.5

4.7

0.27

232

1872

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.95

1.69

1.1

1.2

—

(3049233) Organic acids panel - Urine

2.61

1.67

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

199

1.57

1.65

1.3

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.17

1.64

2.5

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

755

1.28

1.63

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

1.60

1.61

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.33

1.59

1.8

4.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.87

1.59

1.1

nmol/l

265.8

243.9

0.17

(3017509) Phencyclidine [Presence] in Urine

381

1.39

1.52

2.4

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.09

1.52

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

291

1.44

1.52

1.3

1.4

12.7

13.7

0.08

152

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

283

1.45

1.52

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

234

1965

1.16

1.51

1.6

1.9

mg/l

4.6

3.4

2.81

220

1879

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

301

1.43

1.48

1.1

—

(36303858) Crystals [Presence] in Urine

2.44

1.48

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

468

1.34

1.46

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.38

1.45

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

169

1952

0.85

1.40

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

271

2318

1.14

1.39

1.5

1.3

nmol/l

24.7

32.3

5.61

233

2145

(3028679) Herpes simplex virus Ab [Presence] in Serum

213

1792

1.16

1.38

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

214

1802

1.16

1.37

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

364

1.37

1.1

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.07

1.36

1.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

171

1.54

1.33

1.2

1.4

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.87

1.32

1.0

1.1

umol/l

15.0

14.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

220

1.47

1.29

1.0

u/ml

1.8

0.9

0.20

139

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

294

1.40

1.28

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

507

5419

0.91

1.27

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

106

848

1.22

1.23

1.7

2.0

—

(3014891) Appearance of Pleural fluid

247

1.42

1.23

1.7

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

534

1.28

1.22

1.1

1.2

u/ml

0.1

9.0

1.65

118

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.77

1.22

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

199

1.47

1.22

1.6

1.4

24.9

35.4

0.71

130

(3019768) Coxiella burnetii Ab [Presence] in Serum

160

1.53

1.20

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

286

2485

1.13

1.20

2.0

2.2

44.2

41.9

0.57

328

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

1.59

1.19

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

173

1962

0.86

1.19

1.2

1.3

g/l

1.4

1.5

0.66

106

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

210

1790

1.15

1.18

5.7

6.6

—

(3022229) Phosphate [Moles/volume] in Urine

145

1.55

1.18

1.9

2.1

mmol/l

16.1

19.4

0.55

124

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

358

1.34

1.17

1.0

u/ml

0.0

0.2

2.48

211

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

242

2085

1.14

1.17

2.4

2.6

e6/l

915.6

688.3

3.77

116

843

(3020874) Milk IgE Ab [Units/volume] in Serum

242

2087

1.13

1.15

1.0

1.1

u/ml

0.8

3.0

1.41

588

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

139

1.55

1.12

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

175

1481

1.16

1.11

1.7

2.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.95

1.09

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

241

2649

0.89

1.07

3.5

3.8

u/ml

44.8

43.6

0.04

234

2628

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

198

1.43

1.05

1.0

1.1

iu/ml

16.8

15.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

323

1.33

1.05

1.0

u/ml

0.1

0.4

1.07

180

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.00

1.04

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.95

1.03

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.07

1.03

1.0

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.69

1.01

1.0

mmol/l

6.8

5.2

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

2.22

1.00

1.2

1.4

nmol/l

66.8

73.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

996

1.18

1.00

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

160

1.47

0.99

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

260

1.35

0.97

1.7

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

210

1.40

0.97

1.0

—

(3000285) Sodium [Moles/volume] in Blood

277

1.34

0.96

1.2

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

252

1.36

0.96

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

678

1.21

0.95

2.0

2.7

ng/l

81.2

105.9

0.86

353

(3014599) Egg white IgE Ab [Units/volume] in Serum

235

2054

1.12

0.95

1.1

u/ml

0.8

4.4

1.51

492

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.90

0.94

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.90

0.94

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.90

0.94

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.90

0.94

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.90

0.94

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.90

0.94

2.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.76

0.94

1.2

1.3

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.72

0.93

1.0

u/l

142.5

411.0

1.30

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

0.51

0.93

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

171

1.43

0.92

1.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

331

1.30

0.91

1.0

u/ml

0.2

1.6

0.65

173

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

550

1.23

0.90

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

885

0.83

0.89

1.5

1.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

214

1.37

0.88

1.1

u/l

21.2

22.7

0.17

140

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

316

1.30

0.88

2.2

2.3

u/field

0.8

0.6

0.52

316

(3012989) Citrate [Moles/time] in 24 hour Urine

1.78

0.86

2.4

1.2

mmol/24h

2.1

2.3

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

101

1.55

0.86

1.0

u/ml

0.0

0.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

564

1.21

0.84

1.0

1.1

u/ml

0.4

3.7

2.15

403

(3047185) IgG [Mass/volume] in Urine

1.71

0.84

1.1

1.0

—

45.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

302

1.29

0.83

1.0

u/ml

0.0

0.5

2.40

172

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

159

1.41

0.82

1.1

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

111

1.50

0.80

1.0

1.1

mmol/l

-0.9

-2.8

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.71

0.78

2.2

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

120

1.47

0.77

1.4

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

178

1.37

0.77

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

182

0.64

0.76

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.61

0.75

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

129

1.44

0.75

1.1

1.2

umol/24h

0.3

0.8

—

(3006598) pH of Arterial cord blood

113

1.47

0.74

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

585

5390

1.06

0.74

1.6

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.66

0.74

1.3

1.1

3.0

2.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

672

1.18

0.74

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

672

1.18

0.74

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

672

1.18

0.74

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

672

1.18

0.74

1.1

—

(40758292) HTLV I+II Ab panel - Serum

480

0.79

0.72

1.2

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

114

1.46

0.72

13.8

14.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

198

1.33

0.70

2.5

2.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

123

1362

0.88

0.70

5.1

5.9

u/ml

6944.0

3046.3

0.22

272

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

156

1.38

0.70

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

277

1.27

0.68

1.1

umol/24h

2.2

1.7

1.77

277

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

498

1.20

0.68

4.1

5.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

1035

0.87

0.67

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

330

1.24

0.67

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

226

1.30

0.66

3.3

3.8

mg/l

1.8

2.2

0.68

197

(3016031) Almond IgE Ab [Units/volume] in Serum

226

1.30

0.66

1.1

1.0

u/ml

0.1

0.7

3.13

121

(40761995) Spermatozoa Progressive [#/volume] in Semen

472

0.81

0.65

2.9

3.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

323

1.24

0.65

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

204

2183

0.91

0.65

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

471

0.81

0.64

5.8

6.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

324

1.24

0.63

1.0

u/ml

5.0

1.6

0.30

242

(3013336) Amino acids [Identifier] in Serum or Plasma

1.56

0.63

2.4

2.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.60

0.61

1.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

162

1.33

0.58

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.44

0.58

1.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

137

1.36

0.57

1.8

1.6

umol/l

0.7

0.09

102

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

137

1.36

0.57

1.1

1.2

—

14403.1

—

(3010937) Rubella virus Ab [Presence] in Serum

215

1.27

0.56

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

104

1.41

0.56

6.1

9.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

512

5265

0.95

0.56

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.63

0.55

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.58

0.54

2.2

2.4

—

(3026726) Creatinine [Moles/volume] in Specimen

208

1.27

0.53

2.3

2.5

umol/l

330.3

397.6

0.20

201

(3007463) Buprenorphine [Presence] in Urine

139

1.34

0.53

8.1

7.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

467

1.17

0.53

3.3

2.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

549

1.16

0.53

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

513

5261

0.95

0.52

1.1

—

(40768795) Lymph node Pathology biopsy report

252

2640

0.93

0.52

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

175

1.28

0.50

1.0

1.4

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.47

0.50

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

299

1.21

0.50

1.6

1.9

mmol/l

7.1

0.02

(3013762) Body weight Measured

104

0.66

0.48

1.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

1.38

0.48

1.2

1.4

nmol/l

676.1

971.7

0.65

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

212

1.24

0.47

1.0

u/ml

0.1

2.0

1.68

162

(3045142) Bone marrow Pathology biopsy report

288

2647

1.06

0.47

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

126

1.32

0.45

1.2

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

171

1.26

0.43

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.42

0.42

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.40

0.42

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

333

1.17

0.41

1.1

—

(3032641) Amino acids panel - Urine

1.53

0.41

1.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

129

1.29

0.40

1.2

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.39

0.0

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

182

1.23

0.39

1.0

—

(3022475) Manganese [Moles/volume] in Blood

200

0.78

0.39

1.1

1.2

—

(4133840)

806

1.10

0.39

1.1

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

101

0.68

0.39

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

281

1.18

0.39

1.2

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.40

0.38

1.4

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.40

0.38

1.4

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

255

1.19

0.38

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

648

0.89

0.37

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

212

1952

1.06

0.36

1.4

1.3

pmol/l

74.0

84.5

0.18

110

622

(3020650) Glucose [Presence] in Urine

820

1.10

0.36

1.5

1.4

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

105

1.30

0.36

1.1

1.2

g/l

0.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

149

1.25

0.36

1.1

1.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.43

0.35

1.0

1.1

—

(3003338) MCHC [Mass/volume]

25350

248328

0.99

0.35

25.5

15.4

g/l

330.0

332.8

307.65

25169

246596

(4038314)

125

1.25

0.31

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1938

18630

1.02

0.31

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.34

0.31

1.0

1.1

—

(4035726)

2385

22973

1.02

0.30

1.4

—

(3049242) von Willebrand panel - Platelet poor plasma

1.29

0.29

1.5

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

106

964

1.07

0.29

1.2

—

(3022670) pH of Venous cord blood

1.28

0.28

1.1

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

218

1.17

0.28

2.7

pmol/l

69.0

55.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

347

1.13

0.27

2.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

294

0.86

0.27

2.0

2.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.30

0.26

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

327

3083

1.04

0.25

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

127

1170

1.06

0.25

3.2

3.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

184

1.17

0.25

1.0

1.4

—

(3034614) HLA Ag [Interpretation]

1.19

0.24

1.0

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

176

0.83

0.24

3.0

5.8

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

185

1.16

0.23

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

381

1.10

0.22

1.9

1.6

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.9

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

200

1879

1.04

0.21

1.0

u/ml

0.5

0.7

0.28

249

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

327

1.11

0.20

1.0

u/ml

3.7

1.4

0.29

245

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

902

0.94

0.20

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

413

1.09

0.19

2.4

2.0

—

(3015183) Erythrocyte sedimentation rate

177

1662

1.04

0.19

1.3

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

606

5804

1.02

0.19

1.3

ug/l

3.6

0.03

552

5244

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

171

0.86

0.18

6.3

4.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

377

1.09

0.18

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

161

1512

1.04

0.18

1.7

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

115

1072

1.05

0.18

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.17

2.4

5.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

189

0.88

0.16

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

199

0.88

0.15

1.0

1.1

u/ml

5.3

6.4

—

145

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

192

1.12

0.15

1.8

2.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

296

1.09

0.15

1.3

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.13

0.15

4.1

3.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

187

0.89

0.14

1.0

1.1

u/ml

0.7

10.7

0.48

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

104

0.85

0.13

1.6

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

526

0.95

0.12

1.8

2.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

405

1.06

0.11

1.2

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

425

0.94

0.11

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

133

0.88

0.11

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

465

1.05

0.10

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

303

1.06

0.09

3.3

2.9

—

(3013862) HLA-DP [Type]

111

0.88

0.09

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.03

0.08

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

593

1.04

0.08

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

593

1.04

0.08

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

516

1.04

0.08

1.3

1.7

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.81

0.08

1.0

1.4

e6/l

16.6

67.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

134

1.09

0.07

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.86

0.06

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

116

1.10

0.06

1.1

1.0

u/ml

0.1

0.3

—

(40763590) HLA-DQ beta [Type]

108

0.90

0.05

1.0

—

(46236302) HLA-C [Type] by High resolution typing

108

0.90

0.05

1.0

—

(40760409) HLA-A [Type] by High resolution

107

0.91

0.04

1.0

—

(40760410) HLA-B [Type] by High resolution

107

0.91

0.04

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

166

1603

1.01

0.04

2.2

2.7

43.6

39.4

1.81

536

(3007700) Barley IgE Ab [Units/volume] in Serum

156

0.94

0.04

1.0

u/ml

0.1

9.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

593

1.02

0.03

1.2

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

205

0.95

0.03

1.1

u/ml

70.0

28.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

205

0.95

0.03

1.1

u/ml

24.3

22.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

106

0.92

0.03

1.8

3.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

165

0.95

0.03

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

286

1.02

0.01

2.8

3.0

mg/l

2.1

1.1

0.71

195

(3036071) Salmonella sp Ab [Titer] in Serum

103

998

1.01

0.01

1.1

—

(40765096) Chromosome analysis panel by Banding

701

0.99

0.01

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

553

0.99

0.00

1.6

1.9

ug/l

1.9

3.6

0.90

332

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

1.04

0.00

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

110

0.98

0.00

1.1

1.0

u/ml

0.2

0.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

110

0.98

0.00

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

242

1.01

0.00

1.0

u/ml

0.0

1.1

0.91

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

160

1567

1.00

0.00

1.0

ng/l

234.8

335.4

3.64

117

1123

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

176

1.00

0.00

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

191

1.02

0.00

1.2

u/ml

0.1

6.0

2.07

160

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

102

0.96

0.00

1.8

3.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

161

1574

1.00

0.00

1.0

ng/l

881.9

737.9

3.67

114

1089

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

161

1576

1.00

0.00

1.0

ng/l

31.1

42.4

5.21

116

1108

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

185

1.00

0.00

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

111

0.97

0.00

2.0

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.95

0.00

1.0

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.96

0.00

2.0

1.1

69.0

74.7

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.7

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.90

0.00

1.0

1.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.5

—

4.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

3.6

—

140.6

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.01

0.00

1.3

1.1

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.4

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.3

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

571.8

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

0.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_NUTRIDEF – Other nutritional deficiencies

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other nutritional deficiencies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other nutritional deficiencies (E4_NUTRIDEF)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints